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Ting-Hsiang Huang, M.S.
Advisory Professor: Jessica K. Tyler, Ph.D.

The access-repair-restore model for the role of chromatin in DNA repair
infers that chromatin is a mere obstacle to DNA repair. However, here we show
that blocking chromatin assembly of newly-synthesized histones, via knockdown
of the histone chaperones ASF1A, CAF-1 or a mutation that specifically prevents
ASF1 binding to histones, hinders loading of Rad51 onto ssDNA during
homologous recombination, as a consequence of reduced recruitment of the
Rad51 loader MMS22L/TONSL to ssDNA, resulting in persistent RPA foci,
extensive DNA end-resection, and persistent activation of the ATR-Chk1
pathway. By contrast, ASF1 and CAF-1 render the rapid inactivation of ATMChk2 pathway via facilitating histone acetylation to allow the recruitment of ATM
to DSBs for efficient repair by non homologous end joining. Furthermore, in
response to DSB damage, ASF1A is specifically phosphorylated by DNA-PKcs
and potentially other kinases, enhancing its interaction with histones H3.1/H4 and
CAF-1, and promoting the recruitment of MMS22L/TONSL to the damaged DNA
to form the Rad51 nucleofilament during homologous recombination. We
propose a model whereby DSB-induced phosphorylation of ASF1A promotes
transient assembly of newly-synthesized histones onto single-stranded resected
DNA, which serves to recruit TONSL-MMS22L to efficiently form the Rad51
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nucleofilament for strand invasion. As such, we have uncovered an unexpected
role for chromatin assembly in an intermediate stage of homologous
recombination, revealing that chromatin assembly plays an active role in DNA
repair per se.
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Chapter 1
Introduction
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1.1. The DNA Damage response
The inability of cells to accurately perform DNA repair in response to DNA
insults causes cells to become genetically unstable and predisposed to human
diseases including cancer. Cells have evolutionarily developed rapid and efficient
cellular DNA-repair mechanisms, termed DNA damage responses (DDRs) to
sense DNA lesions, spread signals and coordinate the control of cell cycle with
repair processes to maintain genomic integrity. The DDR is an entangled network
which is composed of various components typically classified into four categories
including DNA damage sensors, mediators, signal transducers and effectors
(Sancar et al., 2004) (Fig. 1). The fundamental core element for cells to
accurately conduct complicated DDRs relies on protein-protein interactions giving
rise to proteomic post-translational modifications including phosphorylation,
ubiquitination as well as SUMOylation and protein translocations such as
recruitment and displacement. When cells encounter genomic insults, sensors
are responsible for recognizing DNA lesions and structural alterations in the
genome (Harper and Elledge, 2007). In mammalian cells, Mre11-Rad50-Nbs1
(MRN) complex serves as a sensor that rapidly accumulates at DNA doublestranded break (DSB) sites (Uziel et al., 2003), allowing further DNA end
processing and recruitment of DNA damage mediators to selectively coordinate
with signal transducers and effectors according to cell states. It is appreciated
that one type of effector, called the DNA damage checkpoint proteins, while
activated, would lead to cell cycle arrest that gives cells enough time to fix the
DNA breaks and resume cell cycle progression until repair is completed. If DNA
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lesions are not well resolved, cells are programmed to death, termed apoptosis,
so as to prevent them from passing errors in genetic materials to daughter cells
(Fig. 1).
Figure 1
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Figure 1. The canonical DNA damage response (DDR) pathways in
mammalian cells. The DDR pathways are composed of numerous proteins
to form a complicated network in which the signal transduction is mainly
3

mediated

through

protein-protein

interaction

and

post-translational

modifications (such as phosphorylation, ubiquitination and SUMOylation
etc…) from upstream kinases towards downstream cellular responses.
DNA damage signaling cascade in mammals is typically regulated by ATM
and ATR as well as DNA-PK depending on the type of DNA lesion. These
three signaling pathways have distinct or substitutive functions to each
other.

1.2. Phosphoinositide 3-Kinase-like Kinases (PIKKs)
Phosphoinositide 3 kinase-like kinases are a serine/ theronine kinase family
composed of six members including Ataxia-Telangiectasia Mutated (ATM),
Ataxia-Telangiectasia and Rad3-related (ATR), DNA-dependent Protein Kinase
catalytic subunit (DNA-PKcs), mammalian Target of Rapamycin (mTOR),
Suppressor of Morphogenesis in Genitalia (SMG1) and Transformaion/
Transcription Domain-Associated Protein (TRRAP) (Abraham, 2004). ATM and
ATR as well as DNA-PKcs are regarded as core DNA damage mediators that
facilitate protein-protein interactions and initiate signal transductions by
phosphorylating sequential substrates.
1.2.1. Mechanisms of Ataxia-Telangiectasia Mutated (ATM) Activation
Functional characteristics of ATM in maintaining mammalian genome stability
was first noted in patients with a defect in the ATM gene, leading to severe
developmental

neurodegeneration

disorders,

cerebellar

degeneration,

immunodeficiency, chromosomal instability and incidence of cancer (Rothblum-
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Oviatt et al., 2016). ATM protein exists as a dimer or a high order multimer in an
inactive state (Bakkenist and Kastan, 2003). In the presence of DNA lesions,
intermolecular autophosphorylation of ATM occurs at Serine 1981 site
(ATMS1981p) causing the dissociation of the ATM dimer to monomers and
localization to sites of DNA breaks (Bakkenist and Kastan, 2003). Monomeric
ATM is recruited to DSB ends by the MRN complex (Lee and Paull, 2007). The
epistatic link between ATM and the MRN complex arose from patients with
genetic mutations in Mre11 or Nbs1 sharing common rare clinical syndromes
(Ataxia-Telangiectasia-Like Disorder) with A-T patients (Taylor et al., 2004).
Indeed, MRN knockout mice have embryonic lethality while MRN deficient cells
showed

a

significant

reduction

in

ATM

activation

that

also

affected

phosphorylation of downstream factors such as Chk2 and p53 (Uziel et al.,
2003). However, a recent study indicates ATM activation and its recruitment to
chromatin still occur in the absence of MRN and the inhibition of DNA-PK,
suggesting that even though MRN complex promotes ATM activation, it is not
essential for ATM activation and perhaps helps amplify and sustain ATM activity
in response to DSB (Hartlerode et al., 2015).
DNA end structure also affects ATM activation. ATM recognizes and
favorably interacts with open and unwound DSB ends in vivo with the help of
helicase activities possessed by RAD50 in the MRN complex and in vitro with
dsDNA alone (Paull, 2015). A study showed long 3’or 5’ single-stranded DNA
overhangs inhibit both MRN and ATM binding in mammalian extracts but
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potentiated the activation of ATR in a length-dependent manner, giving rise to a
switch between two PIKK components, ATM and ATR (Shiotani and Zou, 2009).
On top of that, chromatin is regarded as a critical determinant to maintain
efficient and sustained ATM activity. The nucleosome-binding protein HMGN1
has been found to bridge ATM and chromatin through the interaction with histone
H3 lysine 14 acetylation (H3K14ac) which is increased in a HMGN1 dependent
manner upon IR irradiation (Lim et al., 2005). Cells lacking HMGN1 have
attenuated ATM activation and p53 phosphorylation whereas the addition of
histone de-acetyltransferase (HDAC) inhibitor elevated phosphorylation levels of
ATM regardless of HMGN1 during IR treatment, suggesting the involvement of
other acetyltransferases in this process (Kim et al., 2009). Indeed, another
non/histone acetyltransferase Tip60 that is associated with chromatin-bound
histone H3 tri-methylated on lysine 9 (H3K9me3) has been reported earlier than
HMGN1, to function in the activation of ATM by acetylating ATM on lysine 3016
in response to DNA damage (Sun et al., 2005; Sun et al., 2007). Moreover,
histone H4 lysine 16 acetylation (H4K16ac) mediated by the MOF protein and
SETD2-induced tri-methylation on H3 lysine 36 (H3K36me3) have been shown to
promote efficient ATM activation (Carvalho et al., 2014; Sharma et al., 2010).
Taken together, the MRN complex is not the only factor to determine the
activation of ATM, but instead, a growing amount of evidence provides a link
between the context of chromatin and the initiation and / or duration of ATM
activity in response to genomic insults. However, how chromatin structure
transduces DNA damage towards ATM activity mechanistically is still elusive.
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1.2.2. Mechanisms of Ataxia-Telangiectasia and Rad3-related (ATR)
Activation
Unlike ATM that is more responsive to DSBs, the ATR DDR mediator can be
initiated and activated by various types of genomic insults, including DSBs, bulky
adducts and especially SSBs generated from stalled replication fork or DNA end
processing (Fig. 1). Although patients with mutations in ATR share common
characteristics with ataxia-telangiectasia, called Seckel syndrome, most functions
of ATM and ATR in DDR signaling pathways are distinct (Alderton et al., 2004).
Functional characteristics of ATR are mainly described during the replicationrelated DDR. When a replication fork stalls, single-stranded DNA (ssDNA) is
generated on the lagging strand. In addition, different lengths of stretched ssDNA
can be generated during nuclease-mediated DNA repairs, such as nucleotideexcision repair and homologous recombination (HR) following DNA damage. In
order to protect vulnerable ssDNA from further nuclease attacks and forming
secondary structures, replication protein A (RPA) rapidly binds exposed ssDNA,
forming a platform where the ATR-interacting protein (ATRIP) anchors to recruit
ATR to RPA-coated ssDNA (Ball et al., 2005). At dsDNA and ssDNA junctions,
the Rad9-Hus1-Rad1 (9-1-1) complex forms a ring-shaped clamp and associates
with Rad17 to co-regulate ATR activity (Parrilla-Castellar et al., 2004). Notably,
this regulation requires Rad9 interaction with TopBP1 and the participation of
Claspin for optimal ATR activation and phosphorylation of its substrates, for
example, Chk1 (Kumagai et al., 2004). It has been shown that TopBP1 also
interacts with ATRIP via its ATR-activating domain (AAD) and the TopBP17

ATRIP interaction is strengthened by ATR-mediated TopBP1 phosphorylation,
leading to a positive feedback loop in amplifying ATR signals (Yoo et al., 2007).
This process is accompanied by complicated interplays between the above
components upon various cellular circumstances.
Independently of DNA damage, DNA torsional stress caused by highly
condensed chromatin during replication or chromatin structure alterations
resulting from hyper- or hypo-tonic conditions induce a fraction of ATR activation
and its redistribution to nuclear envelope (Kumar et al., 2014). When cells enter
mitosis, ATR is required for chromatin condensation given that in the presence of
ATR inhibitors or in Seckel cells (ATR deficiency) chromatin condensation is
significant delayed (Kumar et al., 2014). Intriguingly, a study indicated that site
specific DNA damage-induced chromatin condensation following chromatin
expansion triggers the initiation of DDR signaling, including ATM and ATR
(Burgess et al., 2014). Both studies offer morphological evidence that chromatin
dynamics affects ATR activity but the details of the mechanistic relationship
requires further investigation.

1.2.3. Mechanisms of DNA-dependent Protein Kinase (DNA-PK) Activation
DNA-PK consists of two components, the Ku heterodimer including two
subunits Ku70 and Ku86 and DNA-dependent protein kinase catalytic subunit
(DNA-PKcs) and is primarily and majorly considered as a core non-homologous
end joining (NHEJ) repair factor (Fig. 1)(Baumann and West, 1998). DNA-PKcs
alone has a weak DNA binding activity (Yaneva et al., 1997) and therefore,
requires Ku heterodimers as a prerequisite to be recruited to DNA regardless of
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end structure but has a higher binding affinity to blunt end and overhangs in a
sequence independent manner (Uematsu et al., 2007). Ku itself forms a ring
structure binding to each side of DNA break ends that subsequently would allow
one DNA-PKcs molecule to assembly at each end (DeFazio et al., 2002). The
presence of activated DNA-PKcs at DNA ends ensures successful and efficient
NHEJ repair. Functional DNA-PKcs relies on multiple phosphorylations in two
important and conserved autophosphorylation clusters of DNA-PKcs (ABCDE
and PQR) in vertebrates (Cui et al., 2005). Based on site mutation and functional
analyses, those phosphorylation sites can be functionally redundant, reciprocal
events, minimally contributing to or very important for DNA repair (Cui et al.,
2005; Neal and Meek, 2011). The current model for DNA-PK activation will be
described below.
In response to DNA lesions, DNA-PKcs molecules are recruited by Ku
heterodimers

to

both

of

the

opposing

ends of

DNA

breaks

in

an

unphosphorylated state followed by synapsis to tether two ends together and a
subsequent series of autophosphorylations (Uematsu et al., 2007), but whether
DNA-PKcs is activated in cis or in trans is not clear. It is believed that DNA-PKcs
phosphorylation initially occurs within the ABCDE cluster, leading to a
conformational change to allow accessibility to the ends of DNA (Ding et al.,
2003). Interestingly, PQR cluster phosphorylation causes a subsequent
conformational change to prevent DNA ends from further nuclease attacks but
allows the process of DNA ligation (Cui et al., 2005). Moreover, the ablation of
ABCDE or PQR cluster phosphorylation results in severe radiosensitive
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phenotypes (Cui et al., 2005). In addition, the 7A mutant (S2056A, T2609A,
S2612A, T2620A, S2624A, T2638A, and T2647A), which did not affect DNAPKcs recruitment, showed delayed kinetics of disassembly from DNA lesions as
compared to the wild type (Uematsu et al., 2007). Taken together, these results
suggest that phosphorylation of DNA-PKcs not only affects its DNA repair activity
but it also modulates DNA-PKcs dynamics on DNA breaks until repair is
complete.
DNA-PKcs belongs to the PIKK family and serves as a serine / threonine
protein kinase having a high preference for phosphorylating targets on SQ/TQ
motifs. Even though it has a variety of downstream targets involved in many
aspects of cellular mechanisms from innate immunity towards gene expression,
regulation of NHEJ repair is the most essential function for DNA-PKcs. Instead of
regulating itself autonomously, DNA-PKcs regulation is also mediated by ATM
and ATR during genomic insults (Vidal-Eychenie et al., 2013). Upon ionizing
radiation, DNA-PKcs is rapidly autophosphorylated at serine 2056 and
phosphorylated at threonine 2609 by ATM (Chen et al., 2007). However, ATR
also contributes towards DNA-PKcs’s activity through T2609 and T2647
phosphorylation in an UV irradiation / replication stress dependent manner
(Yajima et al., 2006). In addition to the interplay between PIKKs, DNA-PKcs’s
activity is associated with cell cycle progression upon normal conditions. It peaks
during G1/S phases if the cell cycle (Lee et al., 1997), corresponding to the fact
that the NHEJ repair is dominant through out the whole cell cycle, except for the
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period between S and mitotic phase during which homologous recombinational
repair is the preferred mechanism used.
Several lines of evidence indicate DNA per se is not the only determinant for
DNA-PK loading to DSBs. Chromatin-associated proteins mobilize DNA-PK to
chromatin in the presence of DNA damage or upon hypoxia (Bouquet et al.,
2011). SIRT6, a H3K9 deacetylase, is recruited to DSB sites and forms a
complex with DNA-PK (McCord et al., 2009). By contrast, cells lacking SIRT6
decrease DNA-PK occupancy on chromatin and display a defect in NHEJ repair
during DSB induction (McCord et al., 2009). Other colleagues observed that
oxygen-deprived hypoxia condition (0.1-1 % O2) is sufficient to induce DNA-PKcs
phosphorylation on S2056 regardless of DNA lesions given that this activation
doesn’t cause the recruitment of DNA ligase XRCC4 on chromatin (McCord et
al., 2009)(McCord et al., 2009). They found that elevated histone acetylation
mediated by hypoxia is the cause of DNA-PK activation to regulate transcriptional
expression of HIF-1 and GLUT1. Together, these above findings provide a
different perspective that epigenetic changes, especially histone acetylation also
contribute to DNA-PK’s activity.

1.3. Cell Cycle Checkpoint
To inherit genetic material to daughter cells accurately, mother cells duplicate
the whole genome followed by cell division strategically in highly monitored and
sequential phases, called the cell cycle. The cell cycle is divided into G1, S, G2
and mitotic (M) phases. However, the cell cycle progression is prohibited from
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entering the next phase until the previous one is completed. Such tightlyexecuted events are mainly coordinated through the post-transcriptional
regulation of cyclin-dependent kinases known as CDKs. CDK is activated by its
association with cyclin and the phosphorylation on a threonine residue in its Tloop region; conversely, the phosphorylation on threonine 14 (T14) and tyrosine
15 (Y15) residues in CDK’s ATP-binding loop by Cdc25 family attenuates CDK
activities (Donzelli and Draetta, 2003). CDK-cyclin complexes are also controlled
by CDK inhibitor families under certain conditions (Day et al.). For example, the
INK4 family, which is one of the two CKI families, interacts with CDK4 and CDK6
to promote G1-S transition whereas the other CKI family, Cip/Kip, causes cell
cycle arrest at G1 phase by binding to cyclins D1-D3, CDK4, CDK6, and cyclin E
(Besson et al., 2008). In addition, the timing of cell cycle checkpoints is set at G1,
G2 and metaphase to guard proper cell cycle progression while cells encounter
environmental stresses, replication fork stalls or DNA damage as detected by cell
cycle surveillance systems. Two checkpoint kinases, Chk1 and Chk2, are
identified in humans as core regulators of checkpoint initiation.
1.3.1. Checkpoint Kinase 1 (Chk1) in the DNA Damage Response
Human Chk1, which is a functional counterpart of Rad53 in yeast, serves as
an essential serine / threonine protein kinase for maintaining genome integrity
and cell cycle arrest. Deletion of Chk1 gene in mice causes embryonic lethality
while Chk1 inhibition in cells leads to increased origin firings of replication and
accumulation of ssDNA, suggesting a critical role of Chk1 in S phase progression
(Petermann et al., 2010). Chk1 not only controls intra-S phase progression but
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also arrests G2/M phase transition upon DNA damage through negative
regulation of the Cdc25 dephosphatase to elevate Wee1-mediated Cdk1
inhibitory

phosphorylation

on

threonine

14

and

tyrosine

15

residues

(Cdk1T14p/Y15p) to prevent cells from premature mitosis entry (Petermann et al.,
2010; Xiao et al., 2003).
Chk1 activation is usually confined to the presence of ssDNA which is rapidly
coated by RPA to form a large complex with ATRIP-ATR, 9-1-1 complex,
TopBP1 and Claspin. The interaction between Claspin and Chk1 on chromatin
allows ATR to phosphorylate Chk1 on its C-terminal serine residues including
serine 317 (Chk1S317p) and serine 345 (Chk1S345p) (Liu et al., 2006). Following
DNA damage, partially phosphorylated Chk1 dissociates from chromatin and
translocates to the cytoplasm where it interacts with the 14-3-3 protein to
facilitate G2/M cell cycle arrest in a phosphorylation-dependent manner (Jiang et
al., 2003; Smits et al., 2006). Intriguingly, immobilized-Chk1 fused with H2B
failed to halt DNA damage-treated Chk1-deficient cells at G2/M phase (Smits et
al., 2006), emphasizing the importance of Chk1 in communicating between
chromatin and regions outside of the nucleus.
Several lines of evidence suggest Chk1 is involved in the homologous
recombination (HR) process, which is further discussed in chapter 1.2. It has
been shown that depletion of Chk1 sensitized cells to hydroxyurea (HU) and
camptothecin (CPT) treatment and reduced the frequency of HR-directed DNA
repair(Sørensen et al., 2005). Chk1 interacts with, and directly phosphorylates,
Rad51 on threonine 309 (Rad51T309p) to promote Rad51 nucleofilament
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formation. Either Chk1 inhibition or expression of non-phosphorylatable
Rad51T309A following hydroxyurea (HU) or gemcitabine treatment gives rise to a
reduction in Rad51 foci, as an indicator of impaired HR (Montano et al., 2013;
Sørensen et al., 2005). In addition, Chk1 also indirectly controls Rad51 loading
onto 3’ protruding ssDNA by phosphorylating the localizer of Rad51, BRCA2, on
its C-terminus (Bahassi et al., 2008), but how Rad51 is being placed on ssDNA
accompanied with the displacement of RPA from ssDNA requires further
investigation.

1.3.2. Checkpoint Kinase 2 (Chk2) in the DNA Damage Response
Unlike Chk1, Chk2 is not an essential gene in mammals but is essential in
yeast (Abraham, 2004; Takai et al., 2000). Chk2 is mainly activated via ATM
phosphorylation on threonine 68 (Chk2T68p) for dimerization initially and
dissociates to a fully active monomer spreading throughout the nucleus (Xu et
al., 2002). Other than ATM, DNA-PKcs, Polo-like kinase-3 (PLK3) as well as the
PML protein have been reported to be involved in Chk2 phosphorylation in
special cases (Li and Stern, 2005; Zannini et al., 2014). In terms of cell cycle
regulation, Chk1 and Chk2 are partially functionally redundant given that they
share some substrates: for example, p53, and CDK25A/C. In response to DSBs,
human Chk1 functions strictly in S and G2 phase to achieve replication fork arrest
whereas human Chk2 causes G1/S and G2/M cell cycle phase arrest through
degradation/translocation of CDC25A/C to prevent the dephosphorylation of
Cdk2 and Cdk1 respectively.
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As

a

DDR

signal

transducer,

Chk2

participates

in

homologous

recombinational repair through phosphorylating key factors, such as Brca1 and
Brca2 (Day et al., 2015; Zhang et al., 2004a). Chk2-induced Brca1
phosphorylation on serine 988 is critical for Brca1 departing from Chk2 to DNA
lesions, which in turn promotes homologous recombinational repair (Abraham,
2004; Lee et al., 2000) or precise end joining (Wang et al., 2006). In addition,
phosphorylation of Brca2 on exon 27 through Chk2 and/or Chk1 dissociates its
interaction with Rad51 (Bahassi et al., 2008), leading to the loading of Rad51 to
promote strand invasion during HR repair. By working in concert with ATM, Chk2
modulates heterochromatin accessibility through phosphorylating KAP1 which
subsequently allows the chromatin remodeler CHD3 and heterochromatin protein
1 (HP1 to dissociate from heterochromatin, relaxing local chromatin
architecture to facilitate DNA repair (Bolderson et al., 2012; Dinant and
Luijsterburg, 2009; Goodarzi et al., 2008). It is unclear how Chk2 is inactivated
after the completion of DNA repair. Chk2 can be degraded by the proteasome or
dephosphorylated via phosphatases PP2A or WIP1 or PP1 in unperturbed
condition (Zannini et al., 2014). However, it needs to be elucidated whether the
above components contribute to turning off DNA damage-induced Chk2
activation.

1.4. Major DNA Repair Pathways in Humans
DNA repair is a highly conserved pathway throughout evolution and has been
specialized into several sophisticated repair mechanisms to cope with a variety of
endogenous or exogenous genomic insults. The DSB is regarded as the most
15

severe damage among all kinds of DNA lesion if unrepaired, it will lead to cell
death. Two main DSB repair pathways in humans are non-homologous
recombination and homologous recombinational repair, which are tightly
correlated with cell cycle progression. How cells determine the pathway choice is
still not entirely clear.

1.4.1. Non-Homologous End Joining (NHEJ)
NHEJ is the predominant DSB repair pathway used in mammalian cells to
achieve prompt, high efficient DNA repair. Ku70, Ku86 and DNA-PKcs proteins
are abundant and flexible enough that they recognize various DNA end
structures throughout the cell cycle that makes NHEJ advantageous for the
timely prevention of genomic instability. Since DNA-PKcs was discussed in 1.2.3,
here the mechanism of NHEJ will be described.

During DSB induction, Ku

heterodimers rapidly bind to DNA ends and tether two adjacent ends together
followed by recruiting DNA-PKcs to cover the exposed end structures. Given that
DNA-PKcs protects DNA from further end processing, it helps initiate NHEJ,
rather than HR. Instead of DNA-PK, this pathway requires other core
components including the endo/exonuclease Artemis, XRCC4-like factor (XLF)XRCC4 and DNA ligase IV.
After

DNA-PKcs

autophosphorylation

at

the

ABCDE

cluster,

the

conformational change of DNA-PKcs allows Artemis access to DNA ends.
Artemis has endo/exonuclease activities to process various types of damaged
DNA overhangs and is specific to open DNA haripins found at the DNA ends
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during V(D)J recombination. However, Artemis is not the only enzyme
possessing

nucleolytic

activities

in

NHEJ

repair.

Polynucleotide

kinase/phosphatase (PNKP), AP endonuclease 1 (APE1), CtIP and tyrosyl-DNA
phosphodiesterase 1 (TDP1) play roles in NHEJ as well (Lees-Miller and Meek,
2003; Povirk, 2012). As a substrate of DNA-PKcs, ATM and ATR, DNA-PKcsmediated Artemis phosphorylation is important for its endonuclease activity. It
also has been reported that Artemis phosphorylation induced by ATM is involved
in G2/M cell cycle arrest after IR irradiation while ATR-mediated Artemis
phosphorylation facilitates recovery from S phase arrest upon UV exposure, but
the mechanism of the impact of ATM and ATR on Artemis’s functions remains
unclear (Chen et al., 2005; Lee et al., 2000; Zhang et al., 2004b). Once DNA end
processing is complete, XLF-XRCC4 and DNA ligase IV form an essential
complex to carry out the ligation step followed by disassociation of the NHEJ
repair machinery.
Given the importance of NHEJ in maintaining genomic stability, evidence in
knockout mice has provided clear links between NHEJ and diseases. For
example, Ku deficient mice have early aging accompanied with telomere
shortening (Li et al., 2007). DNA-PKcs knockout mice show severe combined
immunodeficiency (SCID), resulting from failed V (D) J recombination (Taccioli et
al., 1998). In addition, sporadic cancers also commonly have abnormal
expression levels of Ku and DNA-PKcs (Bouchaert et al., 2012; Soderlund Leifler
et al., 2010). Taken together, to date numerous studies from the perspective of
DNA repair per se and clinical data have indicated the pivotal roles of NHEJ in
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guarding genomic integrity. However, little is known about whether chromatin
and/or post-translational modifications (PTMs) on histones have an impact on
end joining repair. Therefore, this thesis will mainly focus on DNA repair within
the chromatin context.

1.4.2. Homologous Recombinational (HR) Repair
HR repair, a repair pathway with high fidelity for various DNA lesions
including radiation, genotoxic chemical treatment and replication fork collapse, is
strictly regulated during S/G2 phase during which homologous strands are
present as a matchable template for repairing broken DNA. 3’ to 5’ end resection
from DNA break sites generates a single-stranded region which serves as a
substrate for strand invasion in trans. Multiple factors are involved in the process
of end resection including the MRN complex, C-terminal-binding protein
interacting protein (CtIP), BRCA1, EXO1 and BLM/Dna2 in eukaryotes. MRE11
possesses 5’ to 3’ exonuclease and endonuclease activities. It is believed that
MRE11 nicks DNA by its endonuclease activity to allow the access for DNA
digestion from 5’ to 3’ end and exposes 3’ overhangs of the complementary
strand (Paull and Gellert, 1998). However, it is not sufficient to carry out resection
by the MRN complex alone; instead, MRE11 coordinates with CtIP and Brca1 by
phosphorylating CtIP and stabilizing its levels through CDK2 and their physical
associations to form the MRN-CtIP-BRCA1 complex during S/G2 phase (Buis et
al., 2012). The main role of CtIP in the complex is to enhance MRE11 functions
as well as to recruit other repair factors and its own nuclease activity is widely
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used

in

response

to

complex

DNA

lesions

produced

by

irradiation,

topoisomerase-mediated breaks and other nucleotide-protein adducts but is
dispensable for repair of restriction enzyme-induced clean DNA ends
(Makharashvili and Paull, 2015; Makharashvili et al., 2014; Wang et al., 2014).
Furthermore, a two-step model has been proposed that following the initial end
resection, EXO1 and BLM are required for further extensive resection to
generate a longer 3’ tail (Nimonkar et al., 2011) which is needed for efficient RPA
binding (Fanning et al., 2006). Cells lacking either EXO1 or BLM have minimal
effects on CPT sensitivity and RPA focus formation, which become more severe
upon double-depletion, suggesting a redundant but critical role of EXO and BLM
in the process of end resection (Karanja et al., 2012).
RPA has a very high affinity for ssDNA (dissociation constant Kd is between
10-10~10-8 M) which is greatly dependent on the length of DNA (Iftode et al.,
1999) RPA-coated ssDNA not only protects its integrity but serves as a platform
to recruit various factors, for example, BRCA1, BRCA2 and PALB2 during the
process of HR repair. Paradoxically, RPA binding is highly dynamic so as to
easily remove RPA from ssDNA, possibly through concentration-dependent
exchange with other ssDNA-binding proteins such as Rad51 which has been
proven in vitro (Gibb et al., 2014), but little is known about the exchange
mechanism in vivo.
To initiate strand invasion, Rad51 has to form nucleofilament on ssDNA
following the displacement of RPA. Given that Rad51 shows a higher specificity
to duplex DNA tailed with ssDNA than ssDNA alone (Mazin et al., 2000), the
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localization of Rad51 to resected 3’ DNA tails requires assistance from other
components. Studies in yeast provided strong evidence that Rad52 targets
Rad51 to ssDNA in a competitive situation with RPA (New et al., 1998;
Shinohara and Ogawa, 1998), RAD52 null mice displayed minimal effects on HR
phenotypes, DNA damage sensitivity, viability and fertility (Rijkers et al., 1998),
but RAD52 inactivation became synergistically lethal with BRCA1 and PALB2 as
well as BRCA2 deficiencies and showed severe chromosomal fragility as well as
dramatic reduction in Rad51 focus formation (Feng et al., 2011; Lok et al., 2013).
BRCA2 is also one of the important HR proteins that can load Rad51 onto
ssDNA through its BRC repeats and C-terminal Rad51 binding domain to
displace RPA. BRCA2 requires PALB2 that contains a chromatin-association
motif (Bleuyard et al., 2012) to serve as a scaffold to form the BRCA complex on
chromatin (Sy et al., 2009). Even though a few theories have been proposed,
how RPA is displaced from ssDNA is still poorly understood.
More and more histone modifiers and remodelers including yeast RSC
(human SMARCAD orthologues), nucleolin (Goldstein et al., 2013), INO80 and
SWI/SNF1 have been reported to participate in navigation of the chromatin
structure during the process of DNA break end repair. These above remodelers
slide or remove nucleosomes away from DNA lesions to allow the access of
repair factors. For instance, cells devoid of mammalian IN080 failed in the timely
removal of H2A.Z from damaged chromatin, leading to reduced generation of
ssDNA, leading to impaired HR (Alatwi and Downs, 2015; Gospodinov et al.,
2011). Furthermore, long-range DNA resection requires yeast Fun30 or human
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SMARCAD1 to either take off histones or de-compact nucleosomes, because
otherwise HR would not be able to proceed (Costelloe et al., 2012).

1.5. Chromatin Dynamics in DNA Damage Response
Chromatin is composed of numerous nucleosomes that can be regarded as
an obstacle towards genomic processes in certain situations. A growing number
of studies demonstrate the increase of DNA accessibility within the chromatin,
facilitated by chromatin remodelers, histone modifiers as well as histone
chaperones, promotes DNA repair (Price and D'Andrea, 2013). In addition, the
processes of chromatin disassembly and assembly during DSB repair are
important for cell viability in yeast (Linger and Tyler, 2007; Tyler et al., 1999) The
first discovery of nucleosome disassembly was observed during nucleotide
excision repair of UV-induced DNA damage (Smerdon and Lieberman, 1978).
The removal of histones from around a DSB provides evidence of chromatin
disassembly to increase the accessibility for the DNA repair machinery (Tsukuda
et al., 2005). However, the influence of chromatin disassembly from a DSB is a
reciprocal reaction in which NBS1 and ATM are required for histone removal
(Berkovich et al., 2007). Following the completion of DNA repair, chromatin
structure around the DSB was restored by ASF1/CAF-1-mediated chromatin
reassembly (Chen et al., 2008; Li and Tyler, 2016). The absence of chromatin
assembly after DNA repair led to the persistent activation of the DNA damage
checkpoint kinase, Rad53, in yeast, suggesting an important but still elusive
function of histone loading to turn off DDR signals hen(Chen et al., 2008). To
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date, the current knowledge for DNA repair in the context of chromatin is the
“access-repair-restore” model (Polo and Almouzni, 2015; Soria et al., 2012) (Fig.
2). The DSB repair machinery must be able 1. to recognize DNA lesions within
various chromatin structure to initiate the DDR. 2. to unfold chromatin by
rearranging or evicting local histones around breaks, which allows the access of
repair factors to damage sites. After DNA repair is complete, chromatin
architecture will be restored to ensure the chromosomal integrity and epigenetic
complexity. The fundamental concept of chromatin dynamics relies on the
equilibrium of nucleosome disassembly and assembly. However, given the fact
that chromatin disassembly and assembly are highly intertwined with repair
processes and DDR signaling, it requires further investigations as to whether the
chromatin spatial rearrangement is important in humans during DSB repair and
when chromatin reassembly occurs after DNA damage.
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Figure 2

Figure 2. The Acess-Repair-Restore model. DNA damage and repair occur
in the context of chromatin. To overcome the chromatin barrier, cells have
to (A) first recognize types of DNA lesions for initiating proper cellular
responses and allowing (B) chromatin modifiers/remodelers to rearrange
local chromatin architecture by which (C) repair machineries will easily get
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access to break sites. (D)(E) Histone chaperones will restore the chromatin
during/after completion of repair.
1.5.1. Nucleosome remodelers
There are four families of ATP-dependent nucleosome remodeler complexes
including SWI/SNF, ISWI, CHD and INO80 (Becker and Workman, 2013) All of
these families contain a DNA-dependent ATPase domain to hydrolyze ATP as a
source of energy to break histone-DNA contacts. These remodelers play a critical
role in altering chromatin structure by moving or sliding histones, changing
compositions of histone octamer or facilitating nucleosome spatial arrangements
to cope with various genomic processes. How those remodelers contribute to
chromatin structure depends on their own specialization. For example, SWI/SNF
and CHD are responsible for sliding and ejecting histone octamers on gene
promoters to regulate transcriptional activities (Marfella and Imbalzano, 2007).
The ISWI family functions in spacing nucleosome arrays which gives rise to
transcriptional repression (Badenhorst et al., 2002). Chromatin remodelers also
participate in DNA repair. SWI/SNF, INO80 and SMARCAD1 (See Section
1.4.2.) were shown to have clear roles in homologous recombinational repair and
CHD1 deficiency causes impeded DNA repair (Kari et al., 2016).

1.5.2. Histone chaperones
Histone chaperones are a specialized group of proteins that generally don’t
have enzymatic activities but have two important common characteristics that are
to bind histones and to regulate nucleosome assembly / disassembly (Burgess
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and Zhang, 2013). Histone chaperones can be categorized as H2A-H2B and H3H4 chaperones depending on which core histones they are associated with.
However, some of them can interact with both H2A-H2B and H3-H4, for example,
FACT protein. Histone chaperones have several characteristics, but may not be
applicable to every chaperone. First, histone chaperones shuttle histones from
the cytoplasm to nucleus, for example, ASF1 and NASP proteins. Second,
histone chaperones serve as a reservoir to either store extra histones or to buffer
excess histones to secure enough histone supply, which is a property of ASF1
and NASP. Third, histone chaperones such as ASF1 can synergize with other
downstream chaperones or collaborate with some histone modifiers to deliver
histones or regulate post-translational modifications (PTMs) on histones,
respectively. Lastly, histone chaperones mediate chromatin disassembly and
reassembly (Burgess and Zhang, 2013). Indeed, histone chaperones participate
in genomic processes including DNA replication, repair and transcription. This
thesis will cover three chaperones, as follows.

1.5.2.1. Anti-Silencing Function 1 (ASF1)
Asf1 is named after identifying one of its functional characteristics that is to
suppress the silence of mating type loci in budding yeast when overexpressed
(Roos et al., 1997). However, despite the initial finding in a potential role in
transcriptional activation, ASF1 was identified biochemically as a H3-H4
chaperone that functions as a chromatin assembly factor (Tyler et al., 1999).
Unlike yeast and Drosophila, which have only one Asf1 gene, two paralogs of
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ASF1, ASF1A and ASF1B, which share a highly conserved N-terminal domain
but are very diverse in their C-terminal acidic tails, were found in mammals.
In terms of DNA replication, origin firing and replication fork movement
requires numerous proteins to open up the chromatin and unwind the DNA,
allowing the DNA replication machinery to procede. Studies demonstrate naked
stretches of DNA, which are considered to lack nucleosomes, extend about 300
bp behind and ahead of the replication fork (Gruss et al., 1993). How cells
regulate nucleosome disruption in this case remains elusive. It has been
discovered that ASF1 hands newly-synthesized H3.1-H4 over to another CAF-1
which interacts with PCNA during DNA replication (Fig. 3) to execute histone
deposition on newly-synthesized DNA (Park and Luger, 2008). Newlysynthesized histones are usually acetylated before their assembly including
acetylation of H3 lysine 56 (H3K56ac) (Das et al., 2009). This process requires
mammalian ASF1 presenting new H3 to the pan-acetyltransferase CBP/p300
and then acetylated H3 is passed through CAF-1 onto replicated DNA. Moreover,
ASF1 forms a complex with MCM2-7 at replication sites where it is thought to be
responsible for transferring recycled parental histone H3.1-H4 behind the
replication fork to the newly synthesized DNA (Groth et al., 2007).
As an upstream histone chaperone, ASF1 donates H3.3, which is a
replication-independent H3 variant, to HIRA for transcription-coupled chromatin
assembly (Fig. 3) (Park and Luger, 2008). The enrichment of H3.3 on the
genome corresponds to the profile of RNA polymerase II (RNA PolII) distribution
along the genome, implying that H3.3 incorporation occurs during transcriptional
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elongation and is required for transcriptional regulation (Schwartz and Ahmad,
2005); mechanistically, in budding yeast, Asf1 associates with promoter / coding
regions and assists RNA PolII loading onto chromatin. Interestingly, Asf1 is
responsible for both H3 eviction and incorporation during elongation (Schwabish
and Struhl, 2006). Meanwhile, using Chromatin immunoprecipitation (ChIP)
against H3K56ac, it shows Asf1-mediated acetylation of H3 on lysine 56 is
enriched at promoter regions and facilitates chromatin destabilization at the
PHO5 promoter region in yeast. In agreement, both ASF1 deletion and nonacetylatable H3K56R mutant strains displayed higher levels of H3 at the PHO5
promoter and transcriptional regression (Williams et al., 2008), suggesting that
acetylation of H3K56 promotes local chromatin accessibility via Asf1-mediated
deposition of newly synthesized H3.
In terms of maintaining genomic integrity, our lab has demonstrated in yeast
that ASF1 deletion mutants are highly sensitive to DNA damaging agents (Tyler
et al., 1999). We previously showed that Asf1 participates in the recovery of the
yeast DNA damage checkpoint kinase Rad53 which is a functional ortholog of
human Chk1 (Kumar and Burgers, 2013) through mediating nucleosome
deposition after double-strand break (DSB) repair (Chen et al., 2008), but little is
known about whether and how ASF1 impacts human genome stability and DDR
signal transduction.
Taken together, both isoforms of ASF1 in humans share common features in
buffering excess histone H3.1 and function in concert with CAF-1 to facilitate
replication-coupled chromatin assembly, suggesting that they may possibly
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functionally substitute for each other. Little is known about the function of ASF1B

DNA$damage$

alone. Recently, some reports indicate that ASF1B plays specific roles in breast
cancer proliferation (Corpet et al., 2011) as well as human beta cells proliferation
via depositing H3.3 onto DNA (Paul et al., 2016). ASF1B
is damage$
also required for
DNA$
promoting reproductive capability concomitant with its expression during meiotic
entry in female mice (Messiaen et al., 2016). ASF1A promotes senescence by
mediating SAHA foci formation with assistance from another histone chaperone,
HIRA (Yamane et al., 2011). Therefore, it is possible that the distinct signatures
between two the two ASF1 isoforms result from their flexible C-terminal domains
which may determine binding partners or affect histone associations in various
cellular conditions.
Figure 3
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Figure 3. Outline of ASF1 functions in all genomic processes. ASF1
cooperates with downstream histone chaperones to participate in
depositing histones onto naked DNA during replication, transcription, as
well as DNA repair which has been demonstrated in yeast. Whether ASF1
or other histone chaperones will affect the DDR or DSB repair is unclear in
human cells.

1.5.2.2. Chromatin assembly factor-1 (CAF-1)
CAF-1 is composed of three subunits called p150, p60 and p48 in human
cells. During replication, CAF-1 forms a complex with PCNA at replication forks
to promote chromatin assembly via facilitating H3.1 incorporation onto nascent
DNA (Shibahara and Stillman, 1999). Upon various genomic insults, human cells
lacking CAF-1 fail to put nucleosomes onto replicated regions and are halted at S
phase during cell cycle progression (Hoek and Stillman, 2003). Recent studies
using the SNAP-tagging method to distinguish old and new histones supports a
role for CAF-1 in depositing newly-synthesized H3.1 during nucleotide excision
repair (Adam et al., 2013) Furthermore, studies from several species
demonstrate CAF-1 participates in HR repair (Lewis et al., 2005; Linger and
Tyler, 2005; Song et al., 2007) For example, p150 CAF-1 is recruited to DNA
lesions either to stabilize resected ends or to help recruitment of Rad51 via the
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interaction with HP1 (Baldeyron et al., 2011). Other studies using yeast
revealed the possibility that reduced nucleosome assembly activity in CAF-1
deletion mutants may give rise to reduced recombinational repair efficiency
(Lewis et al., 2005; Song et al., 2007). Song, et al. found the p180 mutant, which
is a counterpart of human p150 in Drosophila has a defect in HR repair which is
rescued by complementation of human p150 (Song et al., 2007). However,
whether maintenance of genome stability is directly impacted by CAF-1 per se, or
is indirectly promoted by the CAF-1 mediated proper epigenetic environment
requires further investigation.
1.5.2.3. Histone regulator A (HIRA) complex
The human HIRA complex has three subunits including HIRA, UBN1 and
CABIN1 (Rai et al., 2011). HIRA protein recieves H3.3/H4 from ASF1, and it
mediates H3.3/H4 deposition into transcriptionaly active promotes and within
gene bodies, behind RNA polymerase II machinery (Pchelintsev et al., 2013).
Recent studies also indicate that HIRA participates in maintaining global
chromatin structure and nucleosome occupancy over the whole genome (Gal et
al., 2015). In light of this function, H3.3 incorporation mediated by the HIRA
complex is responsible for transcription restart after completion of nucleotide
excision repair (Adam et al., 2013) and is also important for mouse development
(Lin et al., 2014). During NHEJ, we recently found that HIRA also promotes
chromatin assembly onto the repaired DNA in human cells (Li and Tyler, 2016).
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1.5.3. Functional characteristics of the MMS22L/TONSL complex
Mms22 was first identified as a repair protein from a yeast mutant screen with
hypersensitivity to methylmethanesulphonate (MMS) (Prakash and Prakash,
1977). Deletion of yeast MMS22 causes replication fork stalling, spontaneous
DNA damage and impeded HR (Vaisica et al., 2011) Given that yeast Mms22
interacts genetically in the same pathway with the histone chaperone Asf1, the
acetyltransferase Rtt109, the cullin protein Rtt101, Rtt107, replisome and Mms1
(Collins et al., 2007), it is believed that Mms22 may promote DNA replication in a
manner potentially related to chromatin. The Daniel Durocher and John Rouse
laboratories found Mms22-like (MMS22L) protein, the Mms22 orthologue in
humans, based on an siRNA screen and blast for homologue analysis,
respectively, and that it associates with both ASF1 isoforms, RPA complex, MCM
complex, histones and the histone chaperone FACT (Duro et al., 2010; O'Donnell
et al., 2010). Consistent with observations in yeast, MMS22L shares common
features with yeast Mms22 in maintaining genomic integrity because cells lacking
MMS22L show G2/M phase arrest, long-lasting 53BP1 foci and impaired HR
pathway caused by defective RAD51 nucleofilament formation (Duro et al., 2010;
O'Donnell et al., 2010). Different from yeast Mms22, MMS22L tightly interacts
with the TONSL protein that is an orthologue of plant TONKTSU. Intriguingly,
ASF1 and H3/H4 remain part of the TONSL/MMS22L complex, implicating that
histone assembly during HR repair may be conserved from yeast to humans.
Their findings conclude that MMS22L/TONSL may localize at ssDNA to facilitate
Rad51 loading (Abraham, 2004; Duro et al., 2010) (O'Donnell et al., 2010). In
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agreement, a recent study further supports this conclusion by in vitro analysis, as
MMS22L/TONSL associates with RPA-coated ssDNA and directly interacts with
Rad51 via MMS22L (Piwko et al., 2016). Moreover, TONSL also recognizes
unmethylated H4 at K20 which is considered as a marker of newly-synthesized
H4 at the replication fork and DNA lesions through its ankyrin repeat domain
(Bleuyard et al.) (Saredi et al., 2016). As a result, we propose that newlydeposited nucleosomes around DNA break ends may facilitate MMS22L/TONSL
complex recruitment, but how MMS22L/TONSL interplays with RPA and histones
on DNA lesions requires further investigation.
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Chapter 2
Materials and methods
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2.1. Cell culture, antibodies, DNA damaging agent treatments
HeLa and human erythroleukemia K562 cells were grown in complete DMEM
and RPMI (Roswell Park Memorial Institute) 1640 Medium at 37°C with 5% CO2,
respectively. For transient transfection, 2 x 106 cells were seeded per 60mm dish
for 24 hours prior to the delivery of plasmid DNA using Lipofectamine 2000
(Invitrogen). To induce DNA damage, cells were generally treated with 40

g/ml

Bleomycin

g/ml

(#9041-93-4,

Cayman

Chemical

Company)

and

0.5

Neocarzinostatin (#N9162, Sigma) for 2 hours followed by harvesting at indicated
time points after washing with PBS. The antibodies used in this study are listed in
Table 1.

Table1. A list of antibodies used in this study.
Antibody Name

Catalogue
number/
company

Applications

Dilution
rates

ASF1A

#2990/ Cell
Signaling

Immunoblotting

1:1000

ASF1B

MA5-14836/
ThermoFisher

Immunoblotting

1:750

ATM

#2873/ Cell
Signaling

Immunoblotting

1:1000

ATR (H-300)

sc-1887/Santa
Cruz

Immunoblotting/
immunofluorescence

1:1000/
1:600

BRCA2

GTX70121/
GeneTex

Immunofluorescence

1:400

CAF-1 p150

sc-133105/Santa
Cruz

Immunoblotting

1:1000

CAF-1 p60

A301-085A/

Immunoblotting

1:1000
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BETHYL
Cdc2

GTX108120/
Genetex

Immunoblotting

1:3000

Chk1

sc-8408/Santa
Cruz

Immunoblotting

1:1000

DNA-PKcs

#4602/ Cell
Signaling

Immunoblotting

1:1000

GAPDH

ab8245/ Abcam

Immunoblotting

1:10,000

HA

MMS-101R/
Covance

Immunoblotting

1:3000

HIRA

#39557/ Active
Motif

Immunoblotting

1:750

Histone H3

ab1791/ Abcam

Immunoblotting

1:600010,000

Histone H4

#39269/ Active
Motif

Immunoblotting

1:1000

KAP1

GTX102226/
GenTex

Immunoblotting

1:3000

MMS22L

ab181047/ Abcam

Immunoblotting

1:1500

Orc2

#51-6875GR/
BD Biosciences

Immunoblotting

1:1500

Rad51

ab213/ Abcam

Immunoblotting/
immunofluorescence

1:1000/
1:600

RPA34

NA19L/
Calbiochem

Immunoblotting/
immunofluorescence

1:3000/
1:1000

TONSL

ab101898/ Abcam

Immunoblotting

1:3000

Ab97351/ Abcam

ChIP

-tubulin

T9026/ SigmaAldrich

Immunoblotting

1:5000

H3K56ac

#39281/ Active
motif

Immunoblotting

1:2000
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H4K16ac

#05-1232/
Millipore

Immunoblotting

1:1000

H4K8ac

#CS205840/
Millipore

Immunoblotting

1:1000

Phospho-ATM
S1981

#200-301-400/
Rockland

Immunoblotting/
immunofluorescence

1:1000/1:800

Phospho-cdc2
(Tyr15)

#9111/ Cell
Signaling

Immunoblotting

1:1000

Phospho-Chk1
S345

#2341/ Cell
Signaling

Immunoblotting

1:1000

Phospho-Chk1
S317

#2360/ Cell
Signaling

Immunoblotting

1:1000

Phospho-RAD9
S328

AP3225a/ Abgent

Immunoblotting

1:1000

Phospho-DNAPKcs T2609

ab18356/ Abcam

Immunoblotting/
immunofluorescence

1:1000/
1:800

Phospho-DNAPKcs S2056

ab18192/ Abcam

Immunoblotting/
immunofluorescence

1:2000/
1:800

Phospho-KAP1
S824

A300-767A
BETHYL

Immunoblotting/
immunofluorescence

1:2000/
1:800

Phospho-RPA
32 S4/S8

A300-245A
BETHYL

Immunoblotting

1:3000

2.2. siRNA and shRNA knockdowns
Sequences for small RNAis against ASF1A and ASF1B were described in a
previous study (Groth et al., 2005) and purchased from Dharmacon. 100 nM of
siASF1A and siASF1B oligonucleotides were mixed with INTERFERin siRNA
transfection

reagent

(#409-10,

Polyplus

transfection)

according

to

the

manufacturer’s protocol to perform ASF1A/B knockdowns for 48 hours. The
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siRNA control was a random scrambled RNA sequence. shRNA lentiviral
plasmids against ASF1A, ASF1B, HIRA, CAF-1, DNA-PKcs, Rad51 and the
control were obtained from the shRNA and ORFeome Core Facility at the
University of Texas MD Anderson Cancer Center (Houston, TX). MMS22L, CtIP
and 53BP1 shRNA plasmids were provided through Memorial Sloan Kettering
Cancer Center (MSKCC) RNAi core (New York, NY). 293T cells were transfected
with shRNA plasmids and the viral packaging vectors pCMV-VSVG and pCMVdR8.2. The culture media containing shRNA virus particles were collected 48 to
72 hours after transfection and stored at -80 °C. To generate shRNA knockdown
cells, cells were incubated with shRNA lentiviral supernatant for 24 hours. After
shRNA lentiviral infection, shRNA knockdowns were selected in 1 g/ml
Puromycin for 48 hours. The knockdown efficiency of each target protein was
determined by Western blotting. Each experiment was repeated at least 3 times
and representative results are shown. All siRNA and shRNA target sequences
used in this study were list in Table 2.
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Table 2. A list of siRNAs and shRNAs used in this study.
siRNA
scrambled
ASF1A
ASF1B
shRNA
scrambled
ASF1A
ASF1B
CAF-1 (p150)
HIRA
DNA-PKcs-2
DNA-PKcs-3
Rad51
MMS22L
CtIP
53BP1

clone ID
D001206-13-05
n.a.
n.a.

Company
Dharmacon
Dharmacon
Dharmacon

Target nucleotide sequence
n.a.
5’ AAUC CAGGACUCAUUCCAGAU 3’
5’ AACAACGAGUACCUCAACCCU 3’

RHS4346
V3LHS_351239
V3LHS_410407
V2LHS_248088
V2LHS_171670
V2LHS_231208
V2LHS_94774
V3LHS_318594
TRCN0000149282
TRCN0000005406
TRCN0000018869

Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Dharmacon
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich

n.a.
5’ TAGATGCCAAAATATTCCT 3’
5’ TAGAACTGAAGTACCTGCT 3’
5’ TCAAGAAGGAGAACTCGCC 3’
5’ TAGAGCATACCAAGATGCC 3’
5’ ATTTCTTGAATCCATGACC 3’
5’ ATGATTCAGACTTTCACTG 3’
5’ TTGGCTTCACTAATTCCCT 3’
5’ GCACCTATGTTGTCAGCAATT 3’
5’ CGTCAGCCTTACAACGCAATA 3’
5’ CCCTTGTTCAGGACAGTCTTT 3’

2.3. Alkaline comet assay
2 x 105 K562 cells were pelleted and washed in 1 x PBS followed by
resuspension in 1ml 1 x PBS buffer. 1 x 104 cells were added to 45 °C prewarmed low melting-point agarose (#16520050, Invitrogen) to make a final 0.5 %
agarose mixture and 50 l was applied to comet slides (#4250-200-03, Trevigen).
The slides were immersed in lysis solution (#4250-010-01,Trevigen) for 1 hour at
4 °C. The slides were immersed in prechilled unwinding buffer (0.3N NaOH and
1mM EDTA, pH13.1) for another 30 minutes at 4 °C followed by electrophoresis
at 1.5 V cm-1 for 15min at room temperature. After electrophoresis, nuclear DNA
was counterstained with CyberGold. 100 cells of each sample (n=2) from x 100
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magnifications images were scored to calculate tail moment (a.u.) using ImageJ
software.

2.4. Immunofluorescence analysis
Cells were plated on poly-L-lysine-coated coverslips for 24 hours. After
bleomycin treatment, coverslips were washed with PBS. For DNA damage foci
analysis, 0.1 % Triton-X-100 in cytoskeletal (CSK) buffer (100 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, 10 mM PIPES (pH 6.8)) was added to permeabilize cells
for 3 minutes at room temperature. Cells were washed once with TBS-T (0.05 %
Tween-20) and fixed with 4 % paraformaldehyde for 10 minutes. Fixed cells were
blocked with 3 % BSA for 30 minutes. Primary antibodies diluted in 3 % BSA
blocking buffer were subsequently incubated with coverslips overnight at 4 °C.
Cells were washed 3 times with TBS-T before incubating with fluorescence
conjugated-secondary antibodies for 1 hour at room temperature in the dark.
After washing in PBS, cells were mounted in prolong gold antifade mountant with
DAPI and kept at 4 °C in the dark. Cells were imaged using a 3i confocal
microscope system or Olympus BX53 camera and were captured using via
ImageJ and photoshop software.

2.5. Protein extraction and immunoblotting
After pelleting cells and washing cells once in PBS, they were resuspended in
pre-chilled RIPA buffer (50 mM Tris-HCl, pH7.4, 1 mM EDTA, 0.5 mM EGTA, 1
% Triton-X-100, 0.1 % Nadeoxycholate, 0.1 % SDS, 150 mM NaCl, protease
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inhibitors (complete Mini EDTA-free, #4693159001, Roche) and phosphatase
inhibitors (PhosSTOP, #4906837001, Roche)) followed by sonication. The cell
debris was removed by centrifugation at 14,000 r.p.m., at 4 °C for 10 minutes.
Supernatants were collected supernatants and protein concentrations quantitated
by Bradford protein assay (#500-0006, Bio-Rad). Equivalent protein amounts
were loaded on SDS-PAGE or Criterion 4-12 % precast gels (#5671085, BioRad). After electrophoresis, proteins

were

transferred

to Nitrocellulose

membrane (#10600048, GE Healthcare Life Sciences) for 90 minutes at 4 °C and
membranes were incubated with 5 % non-fat milk for 1 hour at room temperature
before overnight incubation with diluted primary antibodies at 4 °C. Enhanced
chemiluminescence (ECL) Western blotting substrate (# RPN 3243, Amersham
ECL, GE Healthcare Life Sciences) were used for detection, using a protein
simple analysis machine.

2.6. Ectopic expression of wild type and mutant ASF1A
HA tagged wild type (HA-WT) and mutant human ASF1A (HA-S192A) (a
generous gift from Dr. Yuri M. Moshkin) were expressed from pcDNA3.1 (+)
vector. Other mutations were generated on the HA-WT plasmid by site directed
mutagenesis to make the V94R and S192D substitutions. All the above plasmids
had been made immune to knockdown of endogenous ASF1A by nucleotide
mutation of seed sequence “AGATGC” to “CGAGGC” (Table 2). For transient
transfections, HeLa or ASF1A knockdown cells were transfected with ASF1A
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plasmids using lipofectamine 2000 reagent (#11668500, ThermoFisher Scientific)
for 24 hours.

2.7. Immunoprecipitation
2 x 106 HeLa cells were seeded into 60mm dishes and incubated overnight. HAtagged ASF1A plasmids (HA-WT, HA-V94R, HA-S192A and HA-S192D) were
transfected into cells for 24 hours before harvesting. Cells were then lysed with
pre-chilled modified RIPA buffer (replace 1 % Triton X-100 with 0.5 % NP-40) for
15 minutes on ice. To collect supernatant, lysates were centrifuged at 14,000
r.p.m. at 4 °C for 10 minutes. Cell lysates were precleared with Dynabeads
Protein A (#10001D, ThermoFisher Scientific) for 1 hour followed by incubation
with anti-HA-Agarose (#A2095, clone HA-7, Sigma-Aldrich) for 3 hours at 4 °C.
After centrifugation, the HA-Agarose protein complexes were washed in RIPA
buffer 3 times for 15 minutes and boiled with SDS loading buffer.

2.8. Chromatin fractionation analysis
This analysis was performed as described previously with slight modification
(Méndez and Stillman, 2000). Whole cell extract (WCE) samples were taken from
the same batch of samples used for chromatin fractionation and prepared
separately. Cells harvested from 6-well plates were re-suspended in buffer A (10
mM HEPES, pH7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10 % glycerol, 1
mM DTT, complete Mini (EDTA-free) protease and PhosSTOP phosphatase
inhibitors) before adding an equal volume of buffer A with 0.2 % Triton X-100 and
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was incubated on ice for 4.5 minutes. Cytoplasmic protein fractions were
collected after centrifuge at 1,300 x g, for 4 minutes at 4 °C. The insoluble pellet,
including chromatin, was washed with buffer A and then the supernatant was
aspirated. The pellet was resuspended in buffer B (3 mM EDTA, 0.2 mM EGTA,
1 mM DTT, complete Mini protease and PhosSTOP phosphatase inhibitors) for
15 minutes, followed by centrifugation at 1,700 x g, 4 minutes at 4 °C. Nuclear
protein fractions were obtained from the supernatant. Wash pellet once in buffer
B and apply S7 nuclease and RIPA buffer with 5 mM CaCl2 to each sample for
10 minutes on ice, followed by sonication to solubilize. This is referred to as the
“chromatin” sample.

2.9. Native BrdU resection assay
Cells were seeded in 24-well plates containing coverslips overnight and were
incubated with 30 M BrdU (#550891, BD Biosciences) for an additional 48 hours
followed by the treatment of DNA damaging agents (Bleomycin or CPT) for the
time periods indicated in the figures. CtIP and 53BP1-depleted cells serve as
negative and positive controls, respectively, for DNA end resection. After
treatment, the same steps were carried out that were described in the
immunofluorescence analysis except that the diluted anti-BrdU antibody (1:400,
#555627, BD Biosciences) was applied to samples at room temperature for 2
hours. Cells were imaged using an Olympus BX53 microscope system and
images were captured via Cell Sense and photoshop software. For measuring
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BrdU intensity, 100 cells of each sample were quantitated by Fiji (ImageJ)
software.

2.10. Real-time PCR and chromatin immunoprecipitation
I-PpoI-based Inducible DSB system
The pBABE-dd-I-PpoI (Addgene #49052) plasmid developed by Michael
Kastan lab was introduced into HCT116 cells upon puromycin selection to obtain
genomic-integrated stable bulk population. For DNA cutting and repair analysis,
Shield-1 (Cheminpharma) was added to a final concentration of 1mM for 3 hours
to stabilize dd-I-PpoI followed by another 30-minute incubation with 4mM 4-OHT
(Sigma). After treatment, drugs were washed off in PBS to allow the process of
DNA repair over time. DNA levels of I-PpoI sites were further quantified by realtime PCR. The mean value ± S.E.M. at each time point was obtained from three
independent experiments. The primer sequences used for detecting DNA levels
were as follows: (SLCO5a1-F-cut: CCCAGTGCTCTGAATGTCAA; SLCO5a1-Rcut: CCATTCATGCGCGTCACTA). DNA levels were normalized to the value of
real-time PCR using the GAPDH (GAPDH-F: TCAGCCAGTCCCAGCCCAAG;
GAPDH-R: GAGAAAGTAGGGCCCGGCTAC) primer set.
Chromatin immunoprecipitation
The procedure for chromatin immunoprecipitation (ChIP) was performed as
described in the previous study (Li and Tyler, 2016). The antibodies against
DNA-PKS2056p and XRCC4 were used. The enriched chromatin was applied to the
real-time PCR analysis. The primer sequences (SLCO5a1F-Left: GCATGAATGG
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ATGAACGAGAT; SLCO5a1R-Left: CAAGCTCAACAGGGTCTTCT) for real-time
PCR flanked the 5’ upstream region which was 200 b.p. distal from the cutting
site. The NHEJ factor occupancy and the input at each time point were
normalized to GAPDH. All data were normalized to the value of untreated sample
as 1.
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Chapter 3
Replication-dependent chromatin assembly affects PIKK
activation and promotes the MMS22L/TONSL mediated transition
from RPA- to Rad51-coated ssDNA during homologous
recombination
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3.1. Introduction and rationale
DNA damage responses occur in the context of chromatin within our cells, which is
the nucleoprotein structure of nuclear DNA wrapped around the outside of octamers of
core histones to form arrays of nucleosome (Kornberg, 1974). The packaging of DNA
into chromatin helps regulate the accuracy and efficiency of the DNA repair process
and the DDR in general (Xu and Price, 2011). For example, histone post-translational
modifications help recruit proteins involved in the DDR to DSBs (Williamson et al.,
2012). Furthermore, histones have been shown to be removed from around DSBs to
enable DNA repair to occur in yeast and human cells (Berkovich et al., 2007; Chen et
al., 2008; Goldstein et al., 2013; Li and Tyler, 2016). The requirement of chromatin
disassembly around the DNA lesion for DSB repair implies that histones are a physical
obstacle for DSB repair, as described in the access-repair-restore model (Polo and
Almouzni, 2015). Intriguingly, reassembly of histones by the concerted action of the
Asf1 and CAF-1 histone chaperones, after DSB repair, is required for turning off the
DNA damage cell cycle checkpoint in yeast (Chen et al., 2008; Kim and Haber, 2009).
The role of chromatin assembly in turning off the DNA damage checkpoint in yeast
appears to be mediated via an interaction between non-histone bound Asf1 (having
donated its histones to the newly-repaired DNA) and the Rad53 kinase (the equivalent
of mammalian Chk2), to prevent further phosphorylation of Rad53 (Tsabar et al.,
2016). Noteworthy, the interaction between Asf1 and Chk2 is not conserved in
metazoans (Tamburini and Tyler, 2005) suggesting that this mechanism for checkpoint
inactivation after DSB repair is likely to be yeast specific. As such, it is currently
unknown whether chromatin assembly contributes to the repair of DSBs or whether
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chromatin assembly plays a role in inactivation of the DNA damage checkpoint after
DNA repair in metazoans.
There is circumstantial evidence supporting a link between chromatin assembly
and DSB repair in mammalian cells. One of the two mammalian isoforms of Asf1,
ASF1A, is required for chromatin assembly after NHEJ in human cells (Li and Tyler,
2016), although this chromatin assembly is not required for DNA repair via NHEJ per
se. In addition, both human ASF1A and ASF1B exist in a complex with MMS22L and
TONSL (Duro et al., 2010). MMS22L/TONSL is recruited to ssDNA coated with
replication protein A (RPA) to facilitate efficient loading of the strand exchange protein
Rad51 foci onto ssDNA (Duro et al., 2010; O'Donnell et al., 2010; Piwko et al., 2016),
which is an intermediate event in homologous recombination necessary for strand
invasion following replication stress or during DSB repair. Noteworthy, recruitment of
TONSL/MMS22L to sites of DNA replication is mediated by the interaction between
TONSL and newly-synthesized histones that lack H4 K20me (Saredi et al., 2016) that
are deposited onto DNA by ASF1A and CAF-1.
In this thesis, given the evolutionary conservation of histone chaperones and
chromatin structural alterations in response to genomic processes, I set out to firstly
determine if the role of chromatin assembly in inactivation of the DNA damage
checkpoint after DSB repair was conserved from yeast to humans. Secondly, I sought
to dissect the impact of histone chaperone-mediated chromatin assembly on DNA
repair. Indeed, I find persistent activation of the ATR-Chk1 pathway and conversely,
faster inactivation of the ATM-Chk2 pathway upon knockdown of human ASF1.
However, in contrast to yeast, persistent checkpoint activity was due to a defect in
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homologous recombination upon depletion of human ASF1. Specifically, I find that
assembly of newly-synthesized histones onto DNA by the ASF1A/CAF-1 pathway is
required for recruitment of TONSL/MMS22L to facilitate Rad51 loading onto resected
DNA to promote strand invasion. I also have uncovered a novel DSB-induced
phosphorylation of ASF1A by the DNA-dependent protein kinase catalytic subunit and
potentially other kinases. Mechanistically, phosphorylation of ASF1A in response to
DSBs increased its interaction with histones and histone chaperones, and promoted
recruitment of MMS22L/TONSL to damaged DNA, enabling Rad51 assembly onto
ssDNA during homologous recombination. Taken together, these studies reveal an
unexpected active role for chromatin assembly, presumably onto ssDNA, during a key
mechanistic stage in the midst of homologous recombination.

3.2. Results
3.2.1. Cells lacking ASF1A or CAF-1 have prolonged Chk1 phosphorylation
and short lasting phosphorylated Chk2 after DSB induction, leading to a
delay in cell cycle progression.
Histones H3 and H4 are rapidly deposited onto DNA following local
microirradiation-induced DNA damage in human cells (Luijsterburg et al., 2016),
suggesting that chromatin is reassembled after DSB repair in humans. Indeed,
ASF1A and CAF-1 mediate the local chromatin reassembly during NHEJ
mediated repair of a DSB induced by the I-PpoI endonuclease in human cells (Li
and Tyler, 2016). Given that chromatin assembly after DSB repair is required for
inactivating the DNA damage checkpoint in yeast (Chen et al., 2008), I asked if
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that was also the case in human cells. I induced global DSBs by treatment of
HeLa cells with the radiomimetic bleomycin, followed by washing out the
bleomycin (time point 0) and collecting samples at increasing time points after
washing out the bleomycin (“post bleo”) (Fig. 4A). I knocked down expression of
ASF1A and ASF1B, using a random scrambled shRNA as a control. In all
experiments, the samples that were not exposed to bleomycin “-“, were
incubated for the same length of time as the longest recovery time after
bleomycin treatment in each experiment, to control for the potential effect of
extensive periods of ASF1A/B knockdown on other cellular processes, such as
DNA replication. For example, knockdown of ASF1A/B in U-2-OS cells has been
shown to lead to RPA accumulation due to defective DNA replication (Groth et
al., 2007) I examined DNA damage checkpoint activation and inactivation during
the bleomycin treatment and recovery in the presence or absence of ASF1A/B,
by western blotting for ATR-mediated phosphorylation of the Chk1 kinase, which
is mainly responsible for the G2/M checkpoint (Liu et al., 2000) and for ATMinduced phosphorylation of the Chk2 kinase. In contrast to the scrambled control
which rapidly inactivates Chk1, I observed persistent phosphorylation of Chk1 at
Ser345 (Chk1S345p) after removal of bleomycin in ASF1 depleted cells. By
contrast, Chk2 phosphorylation at Threonine 68 in the control has a slower
kinetics of disappearance, and Chk2 phosphorylation weakened faster in the
absence of ASF1 during the recovery from DSB damage (Fig. 4A). In
agreement, siRNA knockdown of ASF1A/B also led to persistent Chk1 and
weaker Chk2 phosphorylation in response to DNA damage (Fig. 4B). This
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response was not unique to bleomycin, because cells challenged with another
radiomimetic drug, neocarzinostatin (NCS), also showed persistent activation of
Chk1 and lower levels of Chk2T68p in the absence of ASF1 (Fig. 4C). The
dysregulation of Chk1 and Chk2 phosphorylation in the absence of ASF1A/B
does not appear to reflect stabilization / degradation of either protein, because
there was no difference in Chk1 and Chk2 protein half-life upon inhibition of
translation with cycloheximide (Fig. 4D). Knockdown of ASF1A alone, but not
ASF1B led to the same degree of persistent Chk1 activation; however, both
ASF1 isoforms contribute to the maintenance of Chk2 activation after DNA
damage (Fig. 4E), suggesting that the ASF1A isoform was required for a normal
DNA damage response and ASF1B isoform mainly involved in ATM-Chk2
pathway. In agreement, the persistent Chk1 activation seen upon ASF1A/B
knockdown was rescued by expression of exogenous ASF1A alone while Chk2
phosphorylation was still reduced (Fig. 4F). Taken together, these experiments
indicate that ASF1A is required for timely inactivation of the ATR-Chk1
checkpoint response and both ASF1A and ASF1B participate in maintaining the
activation of ATM-Chk2 pathway following induction of DSBs in human cells.
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Figure 4. ASF1A is required for both timely inactivation of Chk1 and
efficient activation of Chk2. (A) HeLa cells transduced with lentiviruses
expressing scrambed shRNA or shRNA against both ASF1A and ASF1B for
72 hours were treated with 40 g/ml bleomycin for 2 hours, following by
washing out the bleomycin at time 0. Samples were taken at the indicated
time points after washing out the bleomycin, and western blotted for the
indicated proteins or phosphorylation site. (B) Protein expression of
ASF1A/B was silenced by siRNA-mediated knockdown for 48 hours,
followed by bleomycin treatment as described in (A). (C) The phenotypes of
DDR in ASF1 depleted cells are recapitulated after neocarzinostatin (NCS)
treatment. To rule out drug specific effects, cells were incubated with
another radiomimetic DNA damaging agent, NCS (0.5 g/ml) for 2 hours
followed by western blotting analysis. (D) Comparison of the turnover of
Chk1 and Chk2 protein between control and ASF1 knockdown cells. Cells
were treated with 50 g/ml Bleo for 2 hours. 10 g/ml cycloheximide (CHX)
was applied for indicated time periods after Bleo removal. Protein levels of
both Chk1 and Chk2 were detected; H2AX represents the existence of DNA
breaks. (E) Complementation of ASF1A/B knockdowns with a plasmid
expressing ASF1A is sufficient for the timely inactivation of Chk1.
Knockdowns were performed as described in (A), the cells were transiently
transduced with HA-tagged ASF1AWT. 24 hours after transfection, the
experiment was performed as described in (A). (F) Examination of the
effects of ASF1A and ASF1B alone on checkpoint kinase phosphorylation.
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Next, I asked whether the persistent activation of Chk1 in the absence of
ASF1 after DSB induction was accompanied by cell cycle arrest. Chk1 controls
the G2/M cell cycle transition by regulating activities of downstream Cdc proteins,
for example, Cdk1 phosphorylation at Tyr15 (Cdk1 Y15p) through mediating
CDC25A/C degradation (Xiao et al., 2003). Cdk1 acts as critical gatekeeper to
prevent premature entry into mitosis when it is phosphorylated in response to
checkpoint activation (Shaltiel et al., 2015). Inducing DSBs in cells with ASF1
depletion led to persistent Cdk1 Y15p (Fig. 5A). Furthermore, the persistent
phosphorylation of Cdk1 following DSB induction in ASF1 knockdown cells was
Chk1 dependent, because it was abolished by addition of Chk1 inhibitor
AZD7762 (Fig. 5B). In agreement with the persistent phosphorylation of Cdk1,
DSB induction caused cells depleted of ASF1 to accumulate with a G2/M phase
DNA content by flow cytometry (Fig. 5C), consistent with cell cycle arrest.

ASF1 is the upstream histone chaperone for replication-independent
chromatin assembly of histones H3.3/H4 by the HIRA histone chaperone, and for
replication-dependent chromatin assembly of histones H3.1/H4 by the CAF-1
histone chaperone (Hammond et al., 2017). To determine whether either of these
chromatin assembly pathways were required for efficient inactivation of the ATRChk1 pathway after DSB induction, we knocked down HIRA and CAF-1.
Inactivation of HIRA did not lead to persistent Chk1 phosphorylation and
maintained comparable levels of Chk2T68p after DSB induction (Fig. 5D)
indicating that the replication-independent chromatin assembly pathway is not
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involved in inactivation of the ATR-Chk1 and ATM-Chk2 pathways. By contrast,
knockdown of the large subunit of CAF-1, CAF-1 p150, led to persistent Chk1
phosphorylation, a greater reduction of Chk2 phosphorylation and persistent
Cdk1 phosphorylation following DSB induction (Fig. 5E, 3F). Taken together,
these data indicate that the replication-dependent chromatin assembly pathway
plays a role in checkpoint regulation in humans, reminiscent of the situation in
yeast (Chen et al., 2008).
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Figure 5. Depletion of CAF-1, but not HIRA, phenocopies the dysregulated
checkpoint kinases and the delay of cell cycle progression in ASF1
knockdown cells. (A) Robust Cdk1Y15p in the absence of ASF1A/B. The
experiment was performed as described in Fig. 4A, with western blotting
for the indicated proteins or modification. (B) Chk1 plays a major role in
promoting Cdk1Y15 phosphorylation in ASF1 depleted cells. 10 M of Chk1
inhibitor, AZD7762, was added to cells for an hour followed by coincubating with bleomycin for an additional 2 hours. After bleomycin
removal, 10 M of Chk1 inhibitor was re-applied for 12 hours. (C) ASF1depleted cells accumulate in G2/M cell cycle phase while recovering from
DSB damage, as shown by propidium iodide (PI) analysis of DNA content
measure by flow cytometry. (D) HIRA depletion has no significant effect in
affecting Chk1 and Chk2 phosphorylation. (E) CAF-1 depletion leads to
persistent Chk1 and insufficient Chk2 activation accompanied with
prolonged Cdk1 activation following DSB damage.
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3.2.2 Replication-dependent chromatin assembly affects the steady-state
levels of acetylated H3 on Lysine 56 (H3K56ac) and H4 on Lysine 16
(H4K16ac) before and after DSB induction

Replication-dependent chromatin assembly by ASF1 and CAF-1 is promoted by
acetylation of histone H3 on K56, as this modification promotes the transfer of
H3/H4 from Asf1 to CAF-1 in yeast. Acetylated H3K56 levels are rapidly reduced
and reversed in response to DNA damage in human cells (Tjeertes et al., 2009)
Therefore, while H3K56ac levels correlate with chromatin assembly, whether
human ASF1 and other chaperones are involved in the recovery of H3K56ac
after DSB repair remains unclear. I observed HeLa cells devoid of ASF1A or
ASF1B partially reduced H3K56ac levels, which are further decreased upon
double knockdown. Unexpectedly, I found H4K16ac levels were drastically
decreased in the absence of ASF1, as compared to the control. The decreased
acetylation of H3K56 and H4K16 can be reversed by the presence of shRNAresistant ASF1AWT (Figure 5A). We also tested the effects of two ASF1
downstream histone chaperones, CAF-1 and HIRA, on acetylated H3K56 as well
as H4K16. The western blotting analysis showed no significant changes in
H4K16ac but the level of H3K56ac was markedly reduced in CAF-1-depleted
cells whereas it is slightly affected by HIRA knockdown (Fig. 6B). These results
showed that ASF1 and CAF-1 are required for maintaining the homeostasis of
H3K56Ac possibly through newly-synthesized histone assembly. ASF1 alone
may possibly affect H4K16ac via other unknown mechanism(s). To assess the
change of acetylated H3 and H4 in response to DNA damage, I performed a time

59

course of post-radiomimetic drug treatment analysis of histone acetylation levels.
Deacetylation of H3K56 and H4K16 started at 4-hr post-removal of bleomycin
and the acetylation was mostly restored by 24 hours. However, the restoration of
H3K56ac and H4K16ac were impeded in both ASF1A/B and CAF-1-depleted
cells (Fig. 6C), but this was not the case in cells lacking HIRA even though they
show slightly slower kinetics of recovery of acetylation (Fig. 6D). Other histone
acetylations, such as H3K14ac and H4K8ac, were minimally affected, indicating
H3K56ac and H4K16ac may specifically serve as histone markers for
ASF1/CAF-1 mediated nucleosome incorporation.
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Figure 6. ASF1 and CAF-1 mediate the homeostasis of H3K56ac and
H4K16ac before and after DNA damage. Protein levels of H3K56ac and
H4K16ac in the absence of either ASF1 or CAF-1 or HIRA. (A) ASF1 was
silenced either by siRNA or shRNA. After 3-day transduction, ASF1Adepleted cells were transfected with shRNA resistant wild type ASF1A
plasmid for 2 days. (B) CAF-1 and HIRA knockdown cells were collected
and assayed by Western blotting 3 days post lentiviral transduction.
Relative expression levels of H3K56ac and H4K16ac protein were
normalized to H3 and H4, respectively. (C) (D) Histone chaperone-mediated
recovery of H3 and H4 acetylation on specific residues after DNA damage.
Cell with and without knockdown of either ASF1 or CAF-1 or HIRA were
treated with 50 g/ml Bleo for 2 hours followed by various periods of
incubation time after washing away the Bleo.
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3.2.3. ASF1/CAF-1 promote ATM activation and its nuclear localization
Based on the above observations, we sought to dissect the mechanism
behind the phenotype from the DNA damage-signaling pathway. Given that ATM
is known to be the primary kinase of Chk2 in humans, we wanted to understand
whether ASF1 promotes ATM activation to affect signal transduction on Chk2 or
other downstream factors. We also speculated that if this was the case, the
recruitment of ATM to DNA damage sites may be mediated through histone
chaperone-mediated alterations of the chromatin structure. Notably, DNA
damage resulted in the recruitment of ATMS1981p into repair foci at DSB sites.
ATMS1981p accumulation peaks within 4 hours after the removal of the DNA
damaging agent and gradually declined over time (Fig. 7A). In contrast, even
though the punctate ATM focus formation still occurs after the addition of
bleomycin in ASF1-depleted cells, the number of ATM foci is much lower than
control cells (Fig. 7A). Next, to assess whether ATM activity was also affected,
the level of ATM phosphorylation on Serine 1981 which is a marker for its activity
(Kozlov et al., 2006), was determined by western blotting. As expected, the
levels of ATMS1981p upon ASF1 and CAF-1 silencing was reduced at 4 hours after
the removal of bleomycin (Fig. 7B), whereas cells devoid of HIRA didn’t give rise
to a delay in boosting ATM activity (Fig. 7C). In addition, DNA damage-induced
phosphorylation of KAP-1 (KAP-1S824p), which is directly mediated by ATM, was
greatly reduced by knocking down ASF1 and CAF-1 (Fig. 7D). These results
suggest that ASF1/CAF-1 contribute to efficient ATM activation and its
localization to DSBs, leading to the reduced Chk2 and KAP-1 phosphorylation.
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Figure 7
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Figure 7. ASF1 and CAF-1-mediated chromatin assembly contributes to the
maintenance of long-lasting ATM kinase activity
(A) ASF1 promotes Bleo-induced ATMS1981p foci formation. Following the
recovery from 50 g/ml Bleo treatment for 2 hours, cells on coverslips were
pre-extracted according to the immunostainning protocol described in
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Material and Methods. Over 100 cells/ sample/ experiment were randomly
picked to determine the number of foci in nuclei. Error bars were generated
from 3 individual experiments. Effects on ATMS1981p protein levels
responding to Bleomycin in the absence of (B) ASF1 and CAF-1 as well as
(C) HIRA chaperones. (D) Loss of ASF1 and CAF-1 results in attenuated
phosphorylation of KAP-1 after DNA damage.

3.2.4. The replication-coupled chromatin assembly pathway promotes the
transition from RPA-coated ssDNA to Rad51-coated ssDNA during
homologous recombination.

The persistent activation of Chk1 that occurs upon ASF1 and CAF-1
knockdown following DSB induction led us to ask if this is accompanied by
persistent activation of the ATR kinase. By examining the kinetics of
accumulation of ATR at DNA repair foci and dissipation of ATR from DNA repair
foci at increasing times after washing out bleomycin, we observed persistent
accumulation of ATR upon knockdown of ASF1, as compared to the control (Fig.
8A). Consistent with ATR activation by RPA bound to ssDNA, we also observed
persistent retention of RPA at DNA repair foci at increasing times after washing
out bleomycin upon ASF1 knockdown, as compared to the control but not in the
absence of bleomycin (Fig. 8A). RPA is phosphorylated by multiple different
kinases on numerous residues of its RPA2 subunit in response to DSBs resected
to form ssDNA (Marechal and Zou, 2015). In this RPA phosphorylation cascade,
phosphorylation of Ser4/Ser8 by DNA-PKcs appears to be the final event in the
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maturation of DNA damage-induced hyperphosphorylated RPA, where these
phosphorylations specifically delay mitotic entry (Liaw et al., 2011). Furthermore,
Ser4/Ser8 phosphorylation of RPA2 is important for full ATR activation (Liu et al.,
2012). Consistent with there being persistent DSBs resected to ssDNA in cells
depleted of ASF1A/B, we saw persistent Ser4/Ser8 phosphorylation on RPA2
(Fig.

8B) but only after inducing DSBs. While the persistent Chk1

phosphorylation seen in ASF1 depleted cells after DSB damage was blocked by
the ATR inhibitor, VE-821 this was not the case with the RPA2 Ser4/Ser8
phosphorylation (Fig. 8C), consistent with it being mediated by DNA-PKcs. The
persistently activated RPA2 was also observed upon CAF-1 knockdown cells, but
not upon HIRA knockdown (Fig. 8D), indicating that the replication-dependent
chromatin assembly pathway was required for terminating hyperactivated RPA.

To understand the mechanism behind the prolonged ATR-RPA2-Chk1
signalling upon defective replication-dependent chromatin assembly, we asked if
this was due to there being more ssDNA present after DSB induction in ASF1
depleted cells. We used native BrdU immunofluorescence staining to detect
BrdU in ssDNA but not within dsDNA (Raderschall et al., 1999) after exposure of
cells to camptothecin or bleomycin. Camptothecin is a topoisomerase I poison
that induces DSBs during replication. The amount of BrdU at ssDNA upon
depletion of ASF1 was significantly higher than in the control cells following
camptothecin or bleomycin treatment (Fig. 8E). As a control for reduced end
resection during DSB repair, we knocked down the exonuclease CtIP that
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mediates DNA resection (Sartori et al., 2007), and as a control for a situation
where all DSBs would undergo DNA resection, we knocked down the resection
blocking protein 53BP1 (Bothmer et al., 2010). Noteworthy, the amount of end
resection observed upon ASF1 knockdown was comparable to the extreme
amount of resection that occurs upon 53BP1 knockdown. These results suggest
that ASF1 plays a role in protecting DSB ends from excessive resection.

During the process of homologous recombination, RPA is displaced from
ssDNA by an unclear mechanism, and is replaced by Rad51 to form the
nucleofilament that initiates strand invasion. Given that there was persistent RPA
activity and foci formation DSB induction in ASF1 depleted cells, we asked if this
was accompanied by reduced Rad51 nucleofilament formation. Compared to
control cells, we observed a significant reduction in the number of cells with
Rad51 foci after DSB induction in ASF1 depleted cells (Fig. 8F). Consistent with
the reduced recruitment of Rad51 upon ASF1 depletion, we observed a
significant defect in homologous recombination upon ASF1 depletion using a
chromosomally integrated DR-GFP reporter in U2OS cells that allows
homologous gene conversion induced by the I-SceI nuclease (Pierce et al.,
1999) (Fig. 8G). Taken together, the persistent RPA2 foci accumulation and
extensive DNA resection, coupled with the reduced Rad51 loading and impaired
homology gene conversion in the absence of ASF1 after DSB induction, reveal
an important new function of ASF1 in HR.
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Figure 8. ASF1 is required for the efficient replacement of RPA with Rad51
and promotes DNA homologous recombination repair. (A) Prolonged ATR
and RPA2 foci accumulation in the absence of ASF1 following DSB
damage. Cells were treated as described in Fig. 4A. Quantitation of RPA or
ATR foci is shown below, measured from > 100 cells from three
independent experiments, with average and standard deviation plotted. (B)
Robust RPA2 phosphorylation in ASF1 depleted cells following DSB
damage. The experiment was performed as described in Fig. 4A. (C) Robust
RPA2 phosphorylation in CAF-1 depleted cells, but not HIRA depleted cells,
following DSB damage. (D) Accumulation of ssDNA in ASF1 depleted cells
after DSB damage. BrdU fluorescence intensity in nuclei is depicted by
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box-and-whisker plot showing medians (lines in boxes) of n >100, 25 th-75th
percentiles (boxes) and overall ranges. Student’s t-test: ****P < 0.0001. (E)
ASF1 depleted cells are defective in Rad51 nucleofilament formation. Cells
were treated as described in Fig. 4A. Dashed outlines represent nuclei
based on DAPI staining. Quantitation is shown based on the average and
standard deviation from three independent experiments. (F) ASF1 depletion
reduces HR efficiency. The frequency of GFP-positive cells measured by
flow cytometry at 24 hours, 48 hours and 72 hours after I-SceI transduction
in DR-GFP U2-OS cells is shown. Error bars indicate S.E.M.; n=3. t-test:
****P < 0.0001, ***P = 0.0007, *P = 0.0118.
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3.2.5. ASF1 restrains DNA-PKcs autophosphorylation and its accumulation
on chromatin after DSB induction

In terms of the elevated RPA2S4/8p level in bleomycin-challenged ASF1
knockdown cells, it was of interest to understand whether ASF1 affects RPA2S4/8p
through the upstream kinase, DNA-PKcs. When cells were challenged with
bleomycin, DNA-PKcsS2056p accumulated at DNA repair foci and gradually
disappeared over time during recovery from DNA lesions (Fig. 9A). Conversely,
despite the kinetics of DNA-PKcs focus disappearance in ASF1 knockdown cells
being comparable to what was seen in the control, the DNA-PKcs staining
became more intense accompanied with the elevated number of “+” ve stained
cells with the devoid of ASF1 (Fig. 9A). This result was confirmed through flow
cytometry against phospho DNA-PK protein, showing that Bleo-treated ASF1depleted cells from 6 hours during recovery had a 2-fold increase in DNA-PK “+”
ve stained population as compared to the control (Fig. 9B). The specificity for the
antibody against DNA-PKcsS2056p and DNA-PKcsT2609 was confirmed upon DNAPK knockdown by western blotting (Fig. 9C). In addition, I also observed robust
level of DNA-PKcs autophosphorylation at serine 2056 in ASF1 knockdown cells
(Fig. 9C), which was consistent with the prolonged RPA2 s4/8 phosphorylation.
Next, given that DNA-PKcs is pivotal in NHEJ repair, we tested the impact of
ASF1 on the end joining repair process. The I-SceI-mediated GFP reporter
system in which GFP was expressed after the completion of DNA repair via the
NHEJ pathway was used to determine repair efficiency (Mao et al., 2008).
Following I-SceI constitutive expression, the GFP signal in ASF1-depleted cells
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measured by flow cytometry was similar to control cells at Day 3 but was higher
than control cells at Day 4 (Fig. 9D). Next, the inducible DSB cutting / repair
system driven by I-PpoI endonuclease was used to compare DNA repair kinetics
between control and ASF1 depleted cells after DSB induction. We have
previously shown this inducible DSB system is mainly repaired by NHEJ (Li and
Tyler, 2016). By real-time PCR analysis with primers flanking the I-PpoI cutting
site, the ratio of DNA cutting at SLCO5A locus was achieved to ~ 50% which was
defined as “0” time point right after washing off 4-OHT and Shield-1 (Fig. 9E).
With increasing time of recovery, the I-PpoI-induced DSB was nearly completely
repaired in 6 hours (Fig. 9E). When ASF1A was knocked down in HCT116 cells,
the kinetics of DNA repair matched that which was observed in control cells,
indicating that ASF1 does not affect NHEJ-mediated DSB repair in the I-PpoI
system (Fig. 9E). By taking advantage of inducible site-specific breaks, I was
able to validate the impact of ASF1 on the extent of DNA-PKcs (and other
factors) accumulation on chromatin. Chromatin immunoprecipitation (ChIP) was
carried out with phospho-DNA-PKcsS2056 antibodies and the level of target
chromatin near the I-PpoI cutting site was quantitated by real-time PCR. Indeed,
DNA-PKcsS2056p was recruited in the presence of DNA breaks and gradually
disassociated during DNA repair (Fig. 6F). However, depletion of ASF1A
significantly elevated DNA-PKcs mobilization to chromatin adjacent to the break
site at each time point following DSB induction but still caused the dissipation of
DNA-PKcs after completion of DNA repair (Fig. 6F). Similar to DNA-PKcs,
XRCC4, an essential component for DNA ligation during NHEJ was drastically
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enriched at DSBs in the absence of ASF1A (Fig. 6G). Taken together, these
results suggest that ASF1A is required for promoting the timely dissociation of
NHEJ machinery from repaired chromatin.
Figure 9
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Figure 9. ASF1 depletion promotes accumulation of the NHEJ complex on
chromatin at DSB sites. (A) ASF1 negatively regulates the DNA-PKcsS2056p
foci formation in the presence of DNA damage. After exposure to Bleo,
cells were harvested for immunostaining analysis. The percentage of
DNAPKS2056p +ve cells was calculated from over 100 cells / sample /
experiments (n=3). (B) ASF1 depletion leads to an increased population of
DNAPKS2056p + ve cells over time compared to control cells challenged by
50 g/ml Bleomcyin. Cells were harvested at indicated time points followed
by 70% ethanol fixation. Fixed cells were blocked with 3% BSA for 1 hour
and incubated with the DNAPKS2056p antibody for an additional hour. After
conjugated with fluorescent secondary antibody and propidium iodide,
cells were analyzed by flow cytometry. The percentage of DNAPKS2056p +ve
cells is shown in each panel. (C) The level of DNA-PKcs phosphorylation
upon ASF1 knockdown was elevated in response to DNA damage. (D) U2OS cells stably integrated with the I-sceI-GFP-based NHEJ reporter were
transduced with 100 nM of both ASF1A and ASF1B siRNAs for 48 hours
followed by co-transfection with constitutive expressed I-SceI and mCherry
plasmid for 3 and 4 days. After flow analysis, the value of GFP+ was
normalized to mCherry+ as the DNA repair ratio. (E) Impact of ASF1A on
NHEJ-mediated

DNA repair.

The

dd-IPpoI-HCT116

stable

line was

transiently transduced with either shScrambled or shASF1A lentivirus for
72 hours. After the addition of 10 M Shield-1 for 3 hours, cells were
harvested at the indicated time points. Real-time PCR values were
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normalized to GAPDH in each sample. Error bars were obtained from three
individual experiments. (F)(G) Impact of ASF1A on the site-specific DSB
induced-enrichment of DNAPKcsS2056p and XRCC4 on chromatin. 2 g/ml of
DNAPKS2056p and 5 g/ml XRCC4 antibodies were used for ChIP analysis,
respectively, and data were normalized to DNA input.
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3.2.6. Loss of MMS22L phenocopies loss of ASF1 and CAF-1 during
homologous recombination.

Reduced Rad51 loading onto ssDNA in the ASF1 depleted cells could be for
many reasons. However, this was not an indirect consequence of reduced levels
of total Rad51 protein in ASF1 depleted cells, because the Rad51 protein levels
were not changed by ASF1 knock down (Fig. 10A). As discussed above,
MMS22L/TONSL promotes Rad51 nucleofilament formation (Duro et al., 2010;
O'Donnell et al., 2010; Piwko et al., 2016). Given that ASF1 also promoted
Rad51 nucleofilament formation (Fig. 8F) and that ASF1A/B interact with
MMS22L/TONSL (Duro et al., 2010) we investigated the potential of
MMS22L/TONSL and ASF1 functioning in the same pathway to promote Rad51
loading onto resected DNA during HR. Reminiscent of what we observed with
cells depleted of ASF1 or CAF-1, MM22L depletion also led to persistent
phosphorylation of Chk1S345p, RPA2S4/S8p and Cdk1Y15p, following removal of
bleomycin (Fig. 10B, 7C). Like ASF1 depletion, CAF-1 depletion and MMS22L
depletion also led to less Rad51 foci after removal of bleomycin (Fig. 10D). As a
physical measure of a DNA repair defect, we performed comet assays. For these
analyses, we used camptothecin (CPT) because it enriches for DSBs that are
repaired by homologous recombination. Following DSB induction, cells depleted
of ASF1, CAF-1, MMS22L or Rad51 all had long tail moments that were not
statistically different from each other, but were significantly longer than the
control, suggesting that loss of ASF1, CAF-1, MMS22L or RAD51 causes a
similar degree of defect in homologous recombinational repair (Fig. 10E). Taken
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together, these results suggest that MMS22L and the H3.1/H4 chaperones likely
function in the same pathway to promote Rad51 loading onto resected DNA
during DSB repair.
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Figure 10. MMS22L depletion phenocopies depletion of ASF1 or CAF-1. (A)
Comparison of Rad51 protein expression between control and ASF1
knockdown cells. Scrambled and ASF1A/B knockdowns were preformed
with siRNA for 48 hours. (B) DNA damage-induced hyper-phosphorylation
of Chk1 and RPA2 (B) and Cdk1 (C) following MMS22L depletion. The
experiment was performed as described in Fig. 4-5 but with depletion of
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formation 24 hours after bleomycin removal. Shown is the quantitation
from over 100 cells per sample per experiment from three independent
experiments, with the average and standard deviation plotted. (E) Increased
tail moments upon ASF1, CAF-1 and MMS22L depleted cells following DSB
exposure. K562 cells were incubated with 10 M CPT for 2 hours followed
by alkaline comet assay. Comet tail moments were calculated by CaspLab
comet assay software for > 60 cells in each sample. The red line represents
the mean value of tail moment shown in the panel; error bars were obtained
from two individual experiments.
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3.2.7. DNA-PKcs phosphorylates ASF1A at serine 192 in response to DNA
damage

During the course of our analyses, I consistently observed a slower migrating
form of ASF1A appearing within 15 minutes after treatment with the DSB
inducing agents bleomycin and doxorubicin in a dose responsive manner (Fig.
11A, Fig. 11B). This phenomenon was also observed in MEF cells treating with
bleomycin and neocarzinostatin (Fig. 11C). This represents phosphorylated
ASF1A, because the slower migrating form was abolished by treatment with
phosphatase (Fig. 11D). ASF1A is known to be phosphorylated by Tousled-like
kinases (Tlks) (Mello et al., 2002). However Tlks are specifically inhibited by ATM
in response to DNA damage (Groth et al., 2003), indicating that the damageinduced phosphorylation of ASF1A is performed by kinases other than Tlks. In
agreement, we observed that the damage-induced phosphorylation of ASF1A
occurs concomitant with the damage-induced loss of phosphorylation of the Tlks
substrate Rad9 S328 (Sunavala-Dossabhoy and De Benedetti, 2009) (Fig. 11E).
Therefore, we tested whether the DDR kinases were involved and found that
inhibition of neither ATM nor ATR prevented the DSB-induced phosphorylation of
ASF1A (Fig. 11F,G). However, inhibition of DNA-PKcs with either NU-7026 or
NU-7441 significantly reduced the damage induced ASF1A phosphorylation (Fig.
11H, I). As positive controls for DNA-PK inhibition, we examined the DNA-PK
substrate RPA Ser4/8p and Chk1 S345p, given that DNA-PK is known to prime
ATR via its role in RPA phosphorylation (Vidal-Eychenie et al., 2013). ShRNA
knockdown of DNA-PK also reduced damage-induced ASF1A phosphorylation
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(Fig. 11J) in a manner proportional to the efficiency of the knockdown. Finally,
damage-induced ASF1A phosphorylation failed to occur in M059J human
glioblastoma cells that have a frameshift in the gene encoding DNA-PKcs
preventing DNA-PK expression (Allalunis-Turner et al., 1993), while the M059K
cell line made from another region of the same tumor with an intact DNA-PKcs
encoding gene showed ASF1A phosphorylation following DNA damage (Fig.
11K). Given that ASF1A is phosphorylated by Tlks on serine 166, 175, 192 and
199 in the C-terminal tail (Klimovskaia et al., 2014a) we examined whether
mutation of these serines to alanine could block the damage-induced ASF1A
phosphorylation. Indeed, expression of HA-tagged ASF1A with a S192A mutation
blocked its ability to be phosphorylated in response to DNA damage, while wild
type ASF1A-HA was efficiently phosphorylated in response to DNA damage (Fig.
11L). As such, ASF1A is phosphorylated on serine 192 by DNA-PKcs in
response to DSB induction.
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Figure 11. ASF1A is phosphorylated at serine 192 by DNA-PKcs following
DSB damage. (A) Post-translational modification of ASF1A in response to
DNA damage. HeLa cells were treated with increasing concentrations of
bleomycin for 15 and 30 minutes and analysed by Western blotting. Chk1
phosphorylation serves as a DNA damage marker. The asterisk indicates
ASF1A phosphorylation. (B) Induction of ASF1A phosphorylation by
Doxorubicin. An increased dose of Doxorubicin was applied to damage
HeLa cells for 15 or 30 minutes. p53S15p served as an indication of DNA
damage. (C) ASF1A phosphorylation in MEF cells. MEF cells were treated
with bleomycin and NCS for 30 minutes. (D) ASF1A is phosphorylated in
response to DSB damage. Lysates from cells treated with or without
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bleomycin were subject to either alkaline phosphatase (NEB) alone or a
combination of phosphatase and PhosSTOP phosphatase inhibitor cocktail
(Roche) at room temperature for 10 minutes followed by Western blotting
analysis. (E) Rapid inactivation of Rad9 during DNA damage. (F) DSBinduced ASF1A phosphorylation is not mediated by ATM. Cells were
treated with 4 g/ml KU-55933 for one hour followed by co-treatment with
bleomycin for an additional hour. (G) DSB-induced ASF1A phosphorylation
is not mediated by ATR. The experiment was performed as in F, with the 4
g/ml ATR inhibitor VE-821. (H) DSB-induced ASF1A phosphorylation
requires DNA-PK. Inhibition of DNA-PK by 3 g/ml NU-7026 as described in
F. The two asterisks indicate that the antibody against phosphorylated
Chk1 was not effectively stripped from the previous immunodetection. (I)
The addition of DNAPK inhibitors resulted in the reduction of ASF1A
phosphorylation. Following 1-hour pre-incubation with various doses of
NU-7441, cells were challenged by bleomycin for additional one hour.
Chk1S345p was probed in order to monitor DNA-PKcs activities. (J) Control
and two stable DNA-PKcs knockdown cell lines were incubated with or
without bleomycin and analysed by Western blotting. DNA-PKcs, Chk1 and
RPA2

phosphorylation

were

used

as

DNA

damage

markers.

(K)

Comparison of ASF1A phosphorylation between parental (M059K) and
DNA-PKcs deficient (M059J) cell lines to confirm the involvement of DNAPKcs. Phospho Chk1 and Chk2 which are DNAPK and ATM downstream
targets respectively, were blotted to rule out ATM in this pathway. (L) DSB-
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induced ASF1A phosphorylation occurs on serine 192 (S192). Western blot
analysis of ASF1A phosphorylation in cells transiently expressing either Cterminal HA-tagged ASF1A wild type or phospho-block S192A construct for
24 hours. The two asterisks indicate a non-specific band picked up by the
HA antibody. 50 g/ml bleomycin was used in E-L.
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3.2.8. ASF1A phosphorylation facilitates its chromatin localization and
histone binding affinity

We examined

the

potential function

of

damage-induced

ASF1A

phosphorylation by mutating serine 192 to aspartic acid to mimic permanent
phosphorylation. Chromatin fractionation of cellular extracts shows that ASF1
was recruited to chromatin, and this depended on its ability to bind to histones
H3/H4 because the ASF1AV94R mutant which loses histone binding ability
(Antczak et al., 2006) did not interact with chromatin (Fig. 12A). While
comparable levels of ASF1AWT and ASF1AS192A were bound to chromatin, the
ASF1AS192D showed greater binding to chromatin (Fig. 12A), suggesting that the
damage induced ASF1A phosphorylation promotes ASF1A recruitment to
chromatin. When cells were pre-extracted with Triton-X to extract soluble ASF1A
followed by immunofluorescence analysis, 44.6% of the cells had significant
ASF1AS192D retention on the chromatin, as compared to 26 or 29.5% for
ASF1AWT and ASF1AS192A respectively (Fig. 12B). Given that the non-histone
binding ASF1AV94R mutant was maintained on chromatin in only about 0.5% of
cells, chromatin association of ASF1 is likely to reflect its role in chromatin
assembly. As such, it appears that the phosphomimetic of ASF1 is likely to
promote chromatin assembly. In agreement, we observed that phosphorylated
ASF1 was selectively enriched on chromatin during induction of DSBs (Fig.
12C). Furthermore, elevated levels of ASF1 remained on the chromatin at 18 or
24 hours after bleomycin treatment, although it was no longer phosphorylated.
This recruitment and retention of ASF1 on chromatin is likely to depend on prior
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ASF1A S192 phosphorylation, because it was largely blocked upon DNA-PK
inhibition (Fig. 12C). Consistent with ASF1A S192 phosphorylation promoting the
replication-dependent chromatin assembly pathway, we also observed that
ASF1AS192D had enhanced interactions with histone H3.1, H4, and CAF-1 by
immunoprecipitation analysis, in comparison to ASF1AWT and ASF1AS192A (Fig.
12D). Furthermore, ASF1AS192D also promoted interaction with MMS22L (Fig.
12D). By contrast, ASF1AS192D did not increase interaction with H3.3, the
replication-independent histone variant (Fig. 12E). Consistent with the idea that
ASF1 mediated chromatin assembly and MMS22L interaction is upregulated
after DSB induction in a manner dependent on ASF1A phosphorylation, we
observed an increase in the amount of histones and MMS22L bound to wild type
ASF1 after DSB induction, but this did not occur in the S192A mutant (Fig. 12F).
Taken together, these results suggest that DNA damage-induced ASF1A
phosphorylation may promote chromatin assembly and MMS22L interaction.

Figure 12
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Figure 12. Phosphorylation of ASF1A promotes its retention on chromatin
and enhances its association with histones. (A) ASF1A binding to
chromatin is enhanced by phosphorylation. HA-tagged wild type and
mutant ASF1A proteins were transiently expressed in HeLa cells for 24
hours. A portion of each sample was saved as whole cell extract (WCE) and
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the rest was fractionated into cytoplasmic (Cyto), nuclear and chromatin
fractions. Orc2 serves as a control for a known chromatin associated
protein. (B) ASF1A binding to chromatin is enhanced by phosphorylation.
Cells with transient wild type or mutant ASF1A expression were either
subject to immunostaining analysis without pre-extraction to measure
transfection efficiency or with pre-extracting with 0.1% Triton X-100 before
fixation to remove soluble ASF1A protein, allowing the observation of the
chromatin-bound form. 100 cells per sample were counted from two
independent experiments to determine the percentage of cells with
detectable levels of HA-ASF1. (C) Inhibition of DNA-PKcs prevents ASF1A
recruitment to chromatin induced by DNA damage. Cells were pre-treated
with 10 M DNA-PK inhibitors (NU-7026) for 30 minutes followed by an
additional 2-hour co-incubation with 40 g/ml bleomycin. After drug
removal, NU-7026 was re-applied for the indicated time periods. RPA2S4/8p
served as an indication of DNA-PKcs activity. (D) Association of mutant
ASF1A proteins with histones and other chromatin factors was examined
by immunoprecipitation analysis. HeLa cells with wild type or mutant
ASF1A expression were co-transfected with YFP tagged H3.1 for 24 hours.
“Mock” refers to cells treated with lipofectamine 2000 transfection reagent
alone. (E) Phospho-mimetic ASF1A mutant (ASF1AS192D) exhibits increased
association with histone H3.3 interaction. Immunoprecipitation of HAtagged ASF1A mutated proteins with ectopic histone H3.3. HA-tagged
ASF1A plasmids were co-transfected with YFP-tagged H3.3 into HeLa cells
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for 24 hours followed by the IP protocol described in material and methods.
(F) Impact of DNA damage on ASF1A interaction with H3, CAF-1 and
MMS22L upon 20 g/ml Bleomycin treatment. Cellular lysates for HA
immunoprecipitation were prepared as described in Materials and Methods.
Samples with the double “-“ labelling are “untreated” cellular lysates.
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3.2.9.

Damage

induced

ASF1

phosphorylation

promotes

MMS22L

recruitment through newly-assembled histones to facilitate Rad51 loading
Given that DSB-induced phosphorylation of ASF1A enhances ASF1A’s
interactions with chromatin and MMS22L (Fig. 12), we tested whether ASF1A
promotes MMS22L/TONSL recruitment to chromatin. We found that knockdown
of ASF1A greatly reduced the amount of MMS22L and TONSL on chromatin
normally (Fig. 13A) and following induction of DSBs (Fig. 13B). Recruitment of
MMS22L/TONSL to chromatin appeared to be enhanced by the replicationdependent chromatin assembly pathway in general, because knockdown of CAF1, but not HIRA, also reduced MMS22L/TONSL levels on chromatin (Fig. 13A).
To

further

investigate

whether

chromatin

assembly

was

required

for

MMS22L/TONSL-mediated recruitment of Rad51 to sites of DSB repair, we
examined Rad51 recruitment in the ASF1AV94R mutant that is unable to assemble
chromatin. Rad51 recruitment was greatly reduced in the ASF1AV94R mutant (Fig.
13C) indicating that histone binding and presumably chromatin assembly by
ASF1A is required for Rad51 recruitment during HR. Furthermore, the damageinduced phosphorylation of ASF1A appears to also play a key role in HR
because the ASF1AS192A mutant was as defective at Rad51 recruitment as the
ASF1AV94R mutant that fails to bind histones. It has been shown previously that
MMS22L/TONSL is recruited to ssDNA (O'Donnell et al., 2010). Our observation
that

DNA damage-induced

ASF1A phosphorylation

promotes chromatin

assembly in order to recruit MMS22L/TONSL to achieve Rad51 loading onto
ssDNA, suggests an unexpected model whereby chromatin is assembled
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transiently in the midst of homologous recombination, potentially onto ssDNA, to
promote DNA repair per se (Fig. 13D).

Figure 13
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Figure 13. ASF1A-mediated histone deposition is required for the
recruitment of TONSL-MMS22L complex and Rad51 nucleofilament
formation. (A) Level of TONSL-MMS22L complex in chromatin upon histone
chaperone knockdowns, as described in Fig. 9A. (B) ASF1 also facilitates
the recruitment of MMS22L/ TONSL during DNA damage. shScrambled,
shMMS22L and shASF1A/B cells were harvested at the indicated
recovering time points after 2-hour bleomycin (40 g/ml) treatment.
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Samples from the same batch were then prepared for whole cell extracts
(WCE) and chromatin fractions (Chr). (C) Analysis of the ability of wild type
and mutant ASF1A to restore Rad51 nucleofilament formation in ASF1
depleted cells during DNA repair. ASF1A/B depleted cells were transfected
with shRNA-resistant HA tagged wild type and mutant ASF1A plasmids. 24
hours after transfection, cells were transferred to poly-L lysine coated
coverslips and incubated overnight followed by addition of 40 g/ml
bleomycin for 2 hours. Immunostaining was performed 24 hours after
removal of bleomycin. Over 100 cells per sample per experiment were
analysed for the number of Rad51 foci in the nucleus. Quantitation results
were gained from three independent experiments and the average and
standard deviation are shown. (D) Schematic model of histone loadinginduced Rad51 nucleofilament formation. During DNA damage, DNA-PKcsmediated

ASF1A phosphorylation enhances

nucleosome

deposition

through CAF-1 and helps with the recruitment of TONSL-MMS22L complex
towards resected ssDNA. This action triggers Rad51 loading to replace
RPA to enable strand invasion during homologous recombinational repair.

3.3. Discussion
In this study, I have unveiled an unexpected intrinsic role for replicationdependent chromatin assembly in the fundamental mechanism of homologous
recombinational repair. This chromatin assembly is likely to occur on the ssDNA
that results from end resection of DSBs, where the newly-synthesized,
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unmethylated

histones

deposited

onto

the

DNA

function

to

recruit

MMS22L/TONSL to replace RPA with Rad51, to form the nucleofilament that
mediates strand invasion. Furthermore, this function is promoted by ASF1A
phosphorylation in response to DSBs. Our results suggest that dynamic
chromatin assembly plays an active role in the DNA repair process per se.
Consistent with MMS22L/TONSL functioning in the same pathway as
replication-dependent chromatin assembly to achieve Rad51 loading onto DNA,
ASF1 and CAF-1 depletion phenocopied MMS22L knockdown for defects in the
DDR. The extent of the HR defect observed for ASF1 knockdown (Fig. 8G) was
very similar to that reported upon MMS22L and TONSL knockdown using the
ISceI HR reporter system (O'Donnell et al., 2010). Indeed, the DNA damage
repair defects for Rad51, MMS22L, TONSL, CAF-1 and ASF1 knockdown were
indistinguishable by comet assay (Fig. 10E). In agreement, MMS22L, ASF1 and
CAF-1 knockdown all led to the same degree of persistent activation of the ATRRPA-Chk1 pathway and cell cycle arrest (Figs. 3, 4, 7, 9). MMS22L, TONSL,
ASF1, or CAF-1 knockdown, or an ASF1 mutant that cannot be phosphorylated
by DNA-PKcs or an ASF1 mutant that cannot bind histones all resulted in a
similar degree of defect in Rad51 loading (Figs. 10, 11D, 12C). Furthermore,
ASF1 and CAF-1 function upstream of MMS22L/TONSL in the Rad51 loading
pathway,

because ASF1

and

CAF-1 are

required for

recruitment

of

MMS22L/TONSL to chromatin (Fig. 13A). Taken together, all these data indicate
that replication-dependent chromatin assembly is required for MMS22L/TONSL
mediated Rad51 loading onto ssDNA during HR.
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3.3.1. Rad51 loading is promoted by chromatin assembly onto ssDNA
I propose that assembly of chromatin occurs onto ssDNA during HR for the
following reasons. The evidence that MMS22L/TONSL is recruited to RPA-bound
ssDNA produced from DSB processing is compelling (Piwko et al., 2016), as is
the evidence that MMS22L/TONSL is recruited to chromatin via an interaction
with recently deposited histones (Saredi et al., 2016). My work synthesizes these
observations to suggest that chromatin is assembled transiently onto RPA-bound
ssDNA to recruit MMS22L/TONSL to facilitate homologous recombination.
Previous analyses from the Durocher laboratory (O'Donnell et al., 2010)
observed a near perfect accumulation of MMS22L and TONSL at sites of DNA
damage marked by RPA, contained within γH2AX-marked domains. These RPA
containing subchromatin microcompartments have been shown previously to be
delineated

by

ssDNA

(Bekker-Jensen

et

al.,

2006),

indicating

that

MMS22L/TONSL colocalize with ssDNA formed following DSB processing.
Indeed, depletion of CtIP, a protein that plays a key role in end resection
RTORI(Sartori et al., 2007), profoundly reduced MMS22L/TONSL recruitment to
sites of DNA damage (O'Donnell et al., 2010). Furthermore, a recent study
showed that MMS22L, which binds directly to Rad51, is recruited to ssDNA by
RPA (Piwko et al., 2016). Given that TONSL serves as a reader of H4K20me0
(Saredi et al., 2016), which occurs only transiently on newly-synthesized histones
after their assembly onto DNA by ASF1 and CAF-1, my observed requirement for
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ASF1 and CAF-1 for recruitment of MMS22L/TONSL to ssDNA is consistent with
chromatin assembly onto ssDNA following DNA resection.
Several previous studies support the ability of nucleosomes to assemble onto
ssDNA. Nearly 40 years ago, Bruce Alberts reconstituted nucleosomes onto
ssDNA that resembled nucleosomes on dsDNA by electron microscopy (Palter et
al., 1979). Chromatin immunoprecipitation analysis at an unrepairable HO
endonuclease site showed that yeast deleted for the ARP8 gene, encoding a
subunit of the INO80 ATP-dependent chromatin remodeler, maintain histone
occupancy around the DNA lesion even though DNA resection and RPA
recruitment apparently occurred normally, suggesting a possible transient
association between nucleosome and ssDNA in vivo (Tsukuda et al., 2005).
Most recently, DNA resection was shown to be able to occur in vitro on
nucleosomal templates, and that histones remain associated with the ssDNA
after DNA resection (Adkins et al., 2017). I propose that nucleosomes assembled
onto resected ssDNA serves as a platform to specifically recruit DNA repair
machineries, such as MMS22L/TONSL.

3.3.2. Extensive DSB end resection in the absence of ASF1
Unexpectedly, I observed extensive end processing of DSB into ssDNA in
ASF1 depleted cells, equivalent to the levels in cells depleted of 53BP1 (Fig. 8E).
The resection that I observed is strictly dependent on induction of DSBs and is
therefore distinct from the increase in ssDNA that has been reported previously
in the absence of ASF1 (Groth et al., 2007). There are several possible reasons

110

for the extensive DNA end resection that occurs after DSB damage induction in
ASF1 depleted cells. Firstly, it is possible that end-resection continues when the
Rad51 loading step and subsequent strand invasion is blocked. To determine
this possibility, future experiments should measure whether end resection
increases upon Rad51 knockdown. Alternatively, the increased amount of DNA
resection in the absence of ASF1 could be because the chromatin template in
general has a lower nucleosome density (O'Sullivan et al., 2014). If so, this would
indicate that the normal nucleosomal density within our cells serves to restrain
DNA resection.

3.3.3. ASF1/CAF-1 promote ATM activation possibly through histone H4
acetylation on lysine 16
In contrast to the ATR-Chk1 pathway, which is persistently activated in DNA
damage-stimulated ASF1 and CAF-1 knockdown cells, the ATM-Chk2 pathway is
unexpectedly less sensitive to DNA damaging agents. How ASF1/CAF-1mediated chromatin assembly affects ATM recruitment and activity is unresolved
in this thesis. One explanation could be the failure of restoring the level of
H4K16ac in ASF1 and CAF-1 depleted cells during DNA repair. Acetylation of H4
on lysine 16 can be mediated directly by the acetyltransferases hMOF, Tip60 and
indirectly affected via chromatin remodelers Chfr and RNF8 as well as DMAP1
which is a member of Tip60 complex (Penicud and Behrens, 2014; Sharma et al.,
2010; Sun et al., 2005; Wu et al., 2011). Intriguingly, theses proteins have been
reported to play roles in the activation of ATM to some degree. However, like,
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Chfr and RNF8, ASF1 and CAF-1 do not have acetyltransferase activity but still
affect the level of H4K16ac, indicating that the consequence of reduced H4K16ac
in both ASF1 and CAF-1 depleted cells may result from a subsequent effect of
altered nucleosome arrays or other possible histone modifications. It has been
shown that downregulation of H4K16ac modulates chromatin relaxation (Rea et
al., 2007) which may restrict ATM access to damaged DNA. What mechanism
gives rise to the H4K16ac reduction in cells lacking ASF1 and CAF-1 is unclear.
Both ASF1 and CAF-1 facilitate the restoration of H4K16ac during DNA repair
whereas only ASF1 affects preexisting levels of H4K16ac. Asf1 has been shown
to physically interact with the SAS complex that is the yeast homolog of human
Tip60 (Osada et al., 2001), suggesting a possibility that ASF1 cooperates with
the H4 acetyltransferase before depositing newly-synthesized histones onto
chromatin via CAF-1.

3.3.4. DNA-PK mediated phosphorylation of ASF1 drives chromatin
assembly during DSB repair
It may be unexpected but not surprising that DNA-PK serves as a kinase for
ASF1A phosphorylation. DNA-PK binds to and is activated by DNA ends and is
abundant in human cells (Meek et al., 2008), making it an ideal kinase to
stimulate a phosphorylation event specifically in response to DSBs. It seems
logical that in most cases DNA-PK will be the first repair factor to bind a DSB.
Just because DNA-PK is a NHEJ factor, that doesn't automatically confound its
use in promoting chromatin assembly during HR. There are clear examples of
co-localization of NHEJ and HR factors at the same DNA lesion (Schwartz et al.,
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2005). The fact that DNA-PKcs phosphorylates ATM, which is recruited by the
HR factors Mre11-Rad50-Nbs1, indicates that both HR and NHEJ factors bind to
the same DNA ends (Zhou et al., 2017). DNA-PK mediated ASF1AS192
phosphorylation alone stimulates its accumulation on chromatin and is sufficient
to augment formation of complexes with histones, CAF-1, HIRA and TONSLMMS22L (Fig 6D). Future studies will determine exactly how phosphorylation of
ASF1 on S192 in the unstructured C-terminus of ASF1 promotes these
interactions.
It is possible that DNA-PK is not the only kinase for ASF1A
phosphorylation in response to damage, given that this phosphorylation
promotes efficient Rad51 loading while DNA-PK is not required for HR. For
example, it is known that the DNA-PK deficient M059J cell line has reduced ATM
activity. In addition, we find that knockdown of DNA-PK can also affect ATM
activity. It is possible therefore that ATM or some of its downstream kinases may
also phosphorylate ASF1 in a redundant manner with DNA-PK. For that matter, it
is of interest that the sequence around ASF1A S192 fits the consensus site for
Chk2.

3.3.5. ASF1 function may prevent DNA-PKcs from sliding along DNA during
the process of NHEJ repair
Besides ATR and ATM being affected when we impeded chromatin
assembly, DNA-PKcs status was perturbed as well. However, I didn't observe a
significant increase or defect in NHEJ repair efficiency despite the robust
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accumulation of DNA-PKcs on chromatin in ASF1-depleted cells (Fig. 11). Ku
physically serves as a DNA binding subunit for DNA-PKcs and it is known that
instead of binding to DNA termini, the Ku heterodimer has the ability to slide
along the duplex DNA to internal positions (de Vries et al., 1989; Yaneva et al.,
1997). In addition, Ku also associates with nucleosomes but this doesn’t seem to
affect DNA-PKcs kinase activity (Park et al., 2003). However, Ku doesn’t possess
the energy to overcome the nucleosomal barrier, leading to its binding being
limited to DNA ends (remaining within the 20~30bp distal to a break site) (Park et
al., 2003). In agreement with this observation, DNA-PK and XRCC4 were greatly
enriched on DSB ends around which nucleosome density is presumably lower in
cells lacking ASF1 (Fig. 9). Therefore, I propose that timely nucleosome
deposition executed by ASF1 / CAF-1 during the process of NHEJ provides a
spatial barrier to position NHEJ complex at the tip of DNA breaks.

3.3.6. Chromatin assembly on ssDNA mediated by ASF1/CAF-1 promotes
homologous recombinational repair
In agreement with chromatin assembly occurring in the midst of DSB repair,
several studies demonstrate the need for chromatin compaction at break sites
following chromatin expansion/ disassembly to effectively facilitate DNA repair
(Kruhlak et al., 2006; Smeenk and van Attikum, 2013). In line with this notion,
p150 CAF-1 has been shown to promote laser-induced Rad51 nucleofilament
formation by transiently recruiting HP1 (Baldeyron et al., 2011) which
preferentially binds H3K9me3; meanwhile, depletion of CAF-1 in different species
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also compromises HR repair (Lewis et al., 2005; Song et al., 2007). We propose
that local assembly of unmodified newly-synthesized histones facilitates the
recruitment of specific repair factors, such as MMS22L/TONSL at exactly the
time that they are needed to bring Rad51 onto the ssDNA coated with RPA. It
may be relevant that FACT, which is an H2A-H2B chaperone, associates with
RPA (VanDemark et al., 2006), and it will be interesting to investigate if FACT is
also required for efficient Rad51 loading and so could potentially be involved in
the chromatin assembly onto ssDNA. It is possible that the RPA itself plays a
stimulatory role in driving chromatin assembly onto the RPA-ssDNA, given that
the RPA complex binds H3 to facilitate nucleosome assembly in biochemical
experiments (Liu et al., 2017). In this biochemical study, the chromatin assembly
occurred onto naked dsDNA adjacent to the RPA-ssDNA, but the assays
included insufficiently long ssDNA to form a nucleosome on ssDNA.
It is likely that the histones that are assembled by CAF-1 and ASF1 onto
ssDNA during HR are removed upon Rad51 binding. In agreement, the ATPdependent nucleosome remodeler p400 and Rad51 are both required for histone
removal from around an induced AsiSI site in human cells (Courilleau et al.,
2012). While RPA loading and DNA resection occur normally in the absence of
p400, Rad51 is not recruited and histones are not removed from around the DSB
(Courilleau et al., 2012). These data suggest that p400 disrupts the nucleosomes
from ssDNA to enable Rad51 loading onto the ssDNA. The ATP-dependent
nucleosome remodeler BRG1 also promotes removal of RPA and replacement
with Rad51 (Qi et al., 2015), so could also be involved in either the chromatin
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assembly onto ssDNA or chromatin disassembly from the ssDNA. We propose a
model where chromatin is disassembled around a DSB to enable DNA resection
and RPA loading. Next, chromatin is transiently reassembled onto the ssDNA to
recruit Rad51, which itself drives the displacement the histones. After strand
invasion and DNA synthesis have occurred, histones are reassembled once
again onto dsDNA to complete HR (Fig. 13D).
In summary, genomic processes such as DSB repair are facilitated by the
local removal of histones from the DNA, to provide access to the DNA lesion.
However, an unanticipated aspect of the maintenance of genomic stability
revealed by this study is the need for dynamic chromatin reassembly in the midst
of homologous recombination, seemingly onto ssDNA, to promote the specific
recruitment of the MMS22L/TONSL repair machinery in order to recruit Rad51 to
ssDNA. These histones are likely themselves rapidly displaced during Rad51
incorporation onto the ssDNA during Rad51 nucleofilament formation. Such an
active and dynamic role for chromatin assembly to drive the intrinsic steps of
DNA repair is unprecedented.
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Chapter 4
Conclusions and future directions
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There is now a great deal of accumulated evidence showing that chromatin
dynamics mediated by histone remodelers, histone chaperones as well as
histone modifiers is pivotal to various aspects of genomic processes. Changes
on chromatin or more specifically, the pattern of histone modifications and
positioning of nucleosomes, provide not only epigenetic information on histones
per se but spatial organization of the local architecture for cells to sense genomic
alterations, for example, DNA damage. Even though the concept of the reciprocal
association between chromatin and initiation of DNA repair pathways is not
novel, whether nucleosome deposition is needed during the process of DNA
repair is still unclear. In light of this concern, several studies have raised the
concept of “expansion and condensation” of chromatin conformation during the
DNA repair process; however, it is undiscerned whether nucleosome eviction and
deposition occur sequentially or simultaneously around DNA lesions. In
agreement with numerous findings, the work presented here demonstrated
changes in chromatin dynamics (in this case by histone chaperones) affect the
activation and recruitment of PIKK kinases. I discussed some potential
mechanisms that may affect active status of ATM, ATR and DNA-PKcs from the
perspective of lacking chromatin assembly in Chapter 3. The drawback of DNA
damaging agents in experimental schemes is that they generate a variety of DNA
lesions initiating even more complicated cellular responses. Therefore, it is
inevitable in the future that studies will utilize site-specific DNA cutting and repair
systems solely driven by HR (Zhou et al., 2014) and NHEJ pathways respectively
for detail validations of how histone density or PTMs occurring in the absence of
118

histone chaperones contributes to the initiation / recovery of the DDR. For
example, whether the level of H4K16ac around a DSB is required for the
recruitment / maintenance of ATM at later stages of DDR and whether chromatin
assembly during DNA damage induction is a constraint on DNA end processing
and if this is the case, it is quantifiable to measure the length of DNA resection
and determine new components regulating end resection in chromatin-dependent
manner (Zhou et al., 2014).
I coincidentally found that DNA-PK serves as a kinase for ASF1A
phosphorylation at serine 192 residue which is followed by a leucine (SL site).
This DNA-PK dependent non-canonical SQ/TQ site has also been found in XLF,
Ku80 and XRCC4 as well as DNA-PK itself (Lees-Miller and Meek, 2003; Yu et
al., 2008). However, by the addition of selective small molecular inhibitors of
ATM, ATR, Chk1 and DNA-PK (Fig. 11F-I), it is commonly questioned how
specific the targeting drug is. Regarding there being a concern on the drug
specificity, we speculate other kinases may function directly to phosphorylate
ASF1A in a DNA-PK independent manner. Applying the siRNA knockdown or
CAS9 conditional knockout systems to specifically eliminate the expression of
PIKK or other candidates such as Chk1 and Chk2, one will be able to solidify this
finding in the future.
The roles of ASF1A phosphorylation have been identified during DNA
replication (Klimovskaia et al., 2014b) and in the progression of HR described in
Section 3.2.8-9. With the inhibition of DNA-PK kinase activity, ASF1A failed to
get phosphorylated and to reduce ASF1A chromatin recruitment after DNA
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damage (Fig. 12C), illuminating a perspective of ASF1A phosphorylation that
while encountering genomic attacks, cells are urgent to resolve the need for DNA
damage-coupled chromatin assembly. Given that chromatin disassembly and
assembly take place in the NHEJ pathway (Li and Tyler, 2016), our expanding
interest from this point is to understand whether ASF1A phosphorylation
participates in promoting NHEJ-related chromatin assembly by which one can
test out the hypothesis proposed in Section 3.3.5. How the end joining repair
machinery is displaced from repaired DNA has been a long-existing question in
this field. Studies have shown histone deacetylation mobilizes NHEJ components
and promotes repair (Miller et al., 2010; Roos and Krumm, 2016). Therefore, with
the outcome of considerable enrichment of DNA-PKcs and XRCC around a DSB
(Fig. 9G) caused by loss of a histone chaperone, it will be important to know
whether the act of histone deposition or histone PTMs are responsible for
dissipating the DNA-PK complex from intact chromatin after repair is complete.
In the absence of timely nucleosome occupancy at resected DNA, cells
poorly performed the RPA to Rad51 transition nor efficiently recruited the HR
repair machineries which further leads us to propose that nucleosome assembly
on ssDNA participates in the progression of HR. A growing number of evidence
(Section 3.3.1) supports the existence of histone-decorated ssDNA. However,
the current knowledge of nucleosomal ssDNA only relies on in vitro observations
whereas nucleosomes wrapped up into ssDNA in vivo may not yet be
appreciated due to lack of proper techniques for its detection. We combined
characteristics of TONSL, which recognizes newly histone H4 and promotes
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Rad51 nucleofilament, with ASF1 that is a part of TONSL complex and presents
similar phenotypes of stimulating HR repair to suggest the in vivo existence of
nucleosomal ssDNA. We suggest that histone incorporation can occur to serve
as a specific signal for recruiting DNA repair proteins or temporarily stabilize the
unwound DNA structure. To directly prove histones exist on resected DNA, a
system to isolate ssDNA by native BrdU IP from human cells needs to be
established followed by probing for histones. In the future, we will contine to
focus on understanding chromatin dynamics at ssDNA.
Collectively, this study has uncovered the unexpected importance of
ASF1/CAF-1-mediated chromatin assembly in modulating activation of PIKK
kinases and furthermore, suggests nucleosome deposition on ssDNA is a
prerequisite to recruit the Rad51 loading machinery during a key intermediate
step of HR repair.
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